<!DOCTYPE html>
<html lang="fa">
 <meta content="text/html;charset=utf-8" http-equiv="content-type"/>
 <head>
  <title>
   Factors that modify breast cancer risk in women
  </title>
  <link href="d/css/1.css" rel="stylesheet"/>
 </head>
 <body>
  <!-- Start Main Menu Area -->
  <br/>
  <br/>
  <br/>
  <br/>
  <div class="container">
   <div class="row">
   </div>
  </div>
  <section class="teacher-area ptb-10">
   <div class="container">
   </div>
   <section class="course-details-area ptb-60">
    <div class="container">
     <div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
      <h1 style="text-align:center">
       Factors that modify breast cancer risk in women
      </h1>
      <div class="utdArticleSection utdStyle" id="topicContent">
       <div id="topicTitle">
        Factors that modify breast cancer risk in women
       </div>
       <div class="authorSectionElem">
        <div class="authorsElementsLeft">
         <dl id="topicContributors">
          <dt>
           <span>
           </span>
           Author:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Rowan T Chlebowski, MD, PhD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Section Editors:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Anees B Chagpar, MD, MSc, MA, MPH, MBA, FACS, FRCS(C)
           </a>
          </dd>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Daniel F Hayes, MD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Deputy Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Sadhna R Vora, MD
           </a>
          </dd>
         </dl>
        </div>
        <div class="authorsElementsRight">
         <div id="literatureReviewDate">
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             Literature review current through:
            </span>
            Jan 2024.
           </bdi>
          </div>
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             This topic last updated:
            </span>
            Dec 15, 2023.
           </bdi>
          </div>
         </div>
        </div>
       </div>
       <div id="topicWhatsNewContainer">
       </div>
       <div id="topicText">
        <p class="headingAnchor" id="H1">
         <span class="h1">
          INTRODUCTION
         </span>
         <span class="headingEndMark">
          —
         </span>
         Globally, breast cancer is the most frequently diagnosed malignancy and the leading cause of cancer death in women [
         <a href="#rid1">
          1
         </a>
         ]. As an example, breast cancer is the most common cancer in females in the United States and the second most common cause of cancer death in women [
         <a href="#rid2">
          2
         </a>
         ]. Approximately half of breast cancers can be explained by known risk factors, like reproductive factors and proliferative breast disease. An additional 10 percent are associated with family history and genetics. In addition, risk may be modified by demographic, lifestyle, and environmental factors.
        </p>
        <p>
         This topic will review risk factors that modify breast cancer risk in women. Breast cancer chemopreventive medications (
         <a class="drug drug_general" data-topicid="9972" href="/z/d/drug information/9972.html" rel="external">
          tamoxifen
         </a>
         ,
         <a class="drug drug_general" data-topicid="9593" href="/z/d/drug information/9593.html" rel="external">
          raloxifene
         </a>
         , aromatase inhibitors) are reviewed separately. Screening for breast cancer and risk prediction models that can help tailor screening recommendations for breast cancer are discussed separately.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/756.html" rel="external">
          "Selective estrogen receptor modulators and aromatase inhibitors for breast cancer prevention"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/7564.html" rel="external">
          "Screening for breast cancer: Strategies and recommendations", section on 'Breast cancer risk determination'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/753.html" rel="external">
          "Genetic testing and management of individuals at risk of hereditary breast and ovarian cancer syndromes", section on 'Risk assessment models'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H33001831">
         <span class="h1">
          FACTORS ASSOCIATED WITH GREATER BREAST CANCER RISK
         </span>
        </p>
        <p class="headingAnchor" id="H7">
         <span class="h2">
          Increasing age
         </span>
         <span class="headingEndMark">
          —
         </span>
         The risk of breast cancer increases with older age. Using data from the Surveillance, Epidemiology, and End Results (SEER) database, the probability of a woman developing breast cancer in the United States between 2013 and 2015 was [
         <a href="#rid2">
          2
         </a>
         ]:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Birth to age 49 – 2.1 percent (1 in 49 women)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Age 50 to 59 – 2.4 percent (1 in 42 women)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Age 60 to 69 – 3.5 percent (1 in 28 women)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Age 70 and older – 7.0 percent (1 in 14 women)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Birth to death – 12.9 percent (1 in 8 women)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H2354324740">
         <span class="h2">
          Female sex
         </span>
         <span class="headingEndMark">
          —
         </span>
         Breast cancer occurs 100 times more frequently in women than in men. In the United States, over 280,000 women are diagnosed with invasive breast cancer each year, compared with fewer than 3000 cases that occur annually in men [
         <a href="#rid2">
          2
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H8">
         <span class="h2">
          Race/ethnicity
         </span>
         <span class="headingEndMark">
          —
         </span>
         In the United States, the highest breast cancer risk occurs among White women, although breast cancer remains the most common cancer among women of every major ethnic/racial group [
         <a href="#rid2">
          2
         </a>
         ].
        </p>
        <p>
         Many of the racial differences in breast cancer rates are attributable to factors associated with lifestyle. In analyses in a cohort of over 156,000 postmenopausal women, the age-adjusted incidence of breast cancer for White women was higher than for other groups, but adjustment for breast cancer risk factors accounted for the differences for all but African Americans [
         <a href="#rid3">
          3
         </a>
         ].
        </p>
        <p>
         In a separate analysis, using population-based cancer registries from the National Program of Cancer Registries and SEER, the rate of newly diagnosed breast cancer (per 100,000 women) was 124 and 122 for White and Black women, respectively [
         <a href="#rid4">
          4
         </a>
         ]. Despite this, Black women more commonly presented with regional or advanced disease (46 versus 36 percent) and had a 41 percent higher breast cancer-specific mortality rate (30 versus 21 deaths per 100,000 women). One analysis has also suggested that breast cancer in women less than 40 years old and triple-negative breast cancers are more common among African Americans than White Americans [
         <a href="#rid5">
          5
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H9303004">
         <span class="h2">
          Weight and body fat in postmenopausal women
         </span>
         <span class="headingEndMark">
          —
         </span>
         Obesity (defined as body mass index [BMI] ≥30 kg/m
         <sup>
          2
         </sup>
         ) is associated with an overall increase [
         <a href="#rid6">
          6
         </a>
         ] in morbidity and mortality. However, the risk of breast cancer associated with BMI differs by menopausal status. (See
         <a class="medical medical_review" href="/z/d/html/5370.html" rel="external">
          "Overweight and obesity in adults: Health consequences"
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Postmenopausal women
         </strong>
         – A higher BMI and/or perimenopausal weight gain have been consistently associated with a higher risk of breast cancer among postmenopausal women [
         <a href="#rid7">
          7-9
         </a>
         ]. As examples:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         In a meta-analysis of more than 1000 epidemiologic studies, women with a higher BMI experienced a higher risk of postmenopausal breast cancer (relative risk [RR] 1.1 per 5 BMI units, 95% CI 1.1-1.2), particularly estrogen receptor (ER)-positive breast cancer [
         <a href="#rid10">
          10
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         In a separate meta-analysis of 50 studies, for each 5-kg increase in adult weight gain, the RR for postmenopausal breast cancer among no- or low-menopausal hormone therapy users was 1.11 (95% CI 1.08-1.13) [
         <a href="#rid11">
          11
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         The association between a higher BMI and postmenopausal breast cancer risk may be mediated by higher estrogen levels resulting from the peripheral conversion of estrogen precursors (from adipose tissue) to estrogen [
         <a href="#rid12">
          12,13
         </a>
         ]. Arguing for this mechanism are data suggesting that, even among women with normal BMI, a higher body-fat percentage is associated with higher breast cancer risk. In a secondary analysis of the Women's Health Initiative (WHI) cohort, among 3460 postmenopausal women with normal BMI, the multivariable-adjusted hazard ratios (HRs) for breast cancer risk among those with the highest quartile of body fat versus the lowest was 1.89 (95% CI 1.21-2.95) [
         <a href="#rid13">
          13
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         In addition, hyperinsulinemia may also contribute to the obesity-breast cancer relationship because a high BMI is associated with higher insulin levels [
         <a href="#rid14">
          14
         </a>
         ]. (See
         <a class="local">
          'Others'
         </a>
         below.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Of note, estrogen plus progestin increased breast cancer risk in all BMI groups in the WHI randomized trial [
         <a href="#rid15">
          15
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/7427.html" rel="external">
          "Menopausal hormone therapy: Benefits and risks"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Inverse relationship in premenopausal women
         </strong>
         – Unlike postmenopausal women, an increased BMI is associated with a
         <strong>
          lower
         </strong>
         risk of breast cancer in premenopausal women, particularly in early adulthood [
         <a href="#rid16">
          16,17
         </a>
         ]. In a multicenter analysis using pooled individual-level data from approximately 760,000 premenopausal women from 19 prospective cohorts, there was a 4.2-fold increased risk between the lowest and highest BMI categories (BMI &lt;17 versus ≥35) at ages 18 to 24 years [
         <a href="#rid17">
          17
         </a>
         ]. The explanation of this finding remains unclear.
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H9303051">
         <span class="h2">
          Tall stature
         </span>
         <span class="headingEndMark">
          —
         </span>
         Increased height is associated with a higher risk of breast cancer in both premenopausal and postmenopausal women [
         <a href="#rid18">
          18,19
         </a>
         ]. In one study, women who were &gt;175 cm (69 inches) tall were 20 percent more likely to develop breast cancer than those &lt;160 cm (63 inches) tall [
         <a href="#rid20">
          20
         </a>
         ]. The mechanism underlying this association is unknown but may reflect the influence of nutritional exposures during childhood and puberty [
         <a href="#rid21">
          21
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H33002095">
         <span class="h2">
          Benign breast disease
         </span>
         <span class="headingEndMark">
          —
         </span>
         A wide spectrum of pathologic entities is included in the category of benign breast disease. Among these, proliferative lesions (especially those with histologic atypia) are associated with an increased risk of breast cancer. (See
         <a class="medical medical_review" href="/z/d/html/806.html" rel="external">
          "Overview of benign breast diseases"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H2354325194">
         <span class="h2">
          Dense breast tissue
         </span>
         <span class="headingEndMark">
          —
         </span>
         The density of breast tissue reflects the relative amount of glandular and connective tissue (parenchyma) to adipose tissue [
         <a href="#rid22">
          22
         </a>
         ]. Women with mammographically dense breast tissue, generally defined as dense tissue comprising ≥75 percent of the breast, have a higher breast cancer risk compared with women of similar age with less or no dense tissue [
         <a href="#rid22">
          22-26
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/101773.html" rel="external">
          "Breast density and screening for breast cancer", section on 'Breast density and breast cancer risk'
         </a>
         .)
        </p>
        <p>
         In addition, longitudinal increases (or slower decreases in breast density) are associated with an increased risk of breast cancer, while decreases (particularly more rapid ones) are associated with a decreased risk [
         <a href="#rid27">
          27,28
         </a>
         ]. It is unclear whether screening recommendations should differ for women with dense breasts. (See
         <a class="medical medical_review" href="/z/d/html/7564.html" rel="external">
          "Screening for breast cancer: Strategies and recommendations"
         </a>
         .)
        </p>
        <p>
         Breast density does not appear to be associated with a specific breast cancer subtype [
         <a href="#rid29">
          29,30
         </a>
         ] or with higher breast cancer mortality [
         <a href="#rid31">
          31
         </a>
         ].
        </p>
        <p>
         Although breast density is a largely inherited trait, other factors can influence density [
         <a href="#rid32">
          32-35
         </a>
         ]. For example, lower density has been associated with higher levels of physical activity [
         <a href="#rid34">
          34
         </a>
         ] and with a low-fat, high-carbohydrate diet [
         <a href="#rid35">
          35
         </a>
         ]. In postmenopausal women, estrogen and progesterone increase breast density [
         <a href="#rid36">
          36-38
         </a>
         ], while the ER antagonist
         <a class="drug drug_general" data-topicid="9972" href="/z/d/drug information/9972.html" rel="external">
          tamoxifen
         </a>
         decreases breast density [
         <a href="#rid39">
          39,40
         </a>
         ]. Despite the association of exogenous hormones with breast density, breast density is not strongly correlated with endogenous hormone levels [
         <a href="#rid41">
          41
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H1067591809">
         <span class="h2">
          Bone mineral density
         </span>
         <span class="headingEndMark">
          —
         </span>
         Because bone contains ERs and is highly sensitive to circulating estrogen levels, bone mineral density (BMD) is considered a surrogate for long-term exposure to endogenous and exogenous estrogen. In multiple studies, women with higher bone density have a higher breast cancer risk [
         <a href="#rid42">
          42-44
         </a>
         ].
        </p>
        <p>
         In a meta-analysis of eight prospective cohort and two nested-control studies that included over 70,000 postmenopausal women, of whom 1889 developed breast cancer, women in the highest hip BMD category were more likely to develop breast cancer compared with women in the lowest BMD category (RR 1.62, 95% CI 1.17-2.06) [
         <a href="#rid45">
          45
         </a>
         ]. In a 2008 study from the WHI (including 9941 postmenopausal women), each unit increase in the total hip BMD T-score was associated with a higher breast cancer risk (HR 1.25, 95% CI 1.11-1.40) [
         <a href="#rid44">
          44
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/2035.html" rel="external">
          "Clinical manifestations, diagnosis, and evaluation of osteoporosis in postmenopausal women", section on 'T-score'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H2792922212">
         <span class="h2">
          Hormonal factors
         </span>
        </p>
        <p class="headingAnchor" id="H519667554">
         <span class="h3">
          Endogenous estrogen and hormone therapy
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Higher endogenous estrogen levels
         </strong>
         – Higher endogenous estrogen levels are associated with higher breast cancer risk (particularly hormone receptor-positive disease) in both postmenopausal and premenopausal women. For postmenopausal women, the correlation between a higher breast cancer risk and higher hormone levels (eg, estradiol,
         <a class="drug drug_general" data-topicid="107870" href="/z/d/drug information/107870.html" rel="external">
          estrone
         </a>
         ) has been consistent [
         <a href="#rid46">
          46-49
         </a>
         ]. Supporting this concept is the finding that reducing estrogen levels with aromatase inhibitors in postmenopausal women reduces breast cancer risk.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Estrogen level associations with breast cancer risk among premenopausal women can be difficult to measure due to menstrual cycle variations. In a pooled analysis from seven studies, including 767 premenopausal women with breast cancer and 1699 controls, concentrations of estradiol, calculated free estradiol,
         <a class="drug drug_general" data-topicid="107870" href="/z/d/drug information/107870.html" rel="external">
          estrone
         </a>
         , androstenedione, dehydroepiandrosterone, and testosterone were positively associated with breast cancer risk [
         <a href="#rid50">
          50
         </a>
         ]. For example, every twofold increase in estradiol concentration was associated with an odds ratio for breast cancer of 1.19 (95% CI 1.06-1.35). Concentrations of luteal-phase progesterone and calculated free testosterone were not significantly associated with such risk.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Menopausal hormone therapy
         </strong>
         – Combined estrogen/progesterone replacement in women with intact uteri has been shown to increase risk of subsequent ER-positive breast cancer. However, in women with prior hysterectomy, single-agent estrogen replacement has not been associated with increased risk of breast cancer (and is actually associated with reduced risks). The relationship between menopausal hormone therapy and breast cancer is reviewed elsewhere. (See
         <a class="medical medical_review" href="/z/d/html/7392.html" rel="external">
          "Menopausal hormone therapy and the risk of breast cancer"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Contraceptives
         </strong>
         – Breast cancer risk is temporarily increased with current or recent use of combined oral contraceptives, but this association disappeared within two to five years of discontinuation. Additional data on the risks of hormone therapy in young women, particularly centered on estrogen-progestin contraceptives, are discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/7399.html" rel="external">
          "Combined estrogen-progestin contraception: Side effects and health concerns", section on 'Breast cancer'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H630521319">
         <span class="h3">
          Others
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Androgens
         </strong>
         – Preclinical data suggest that androgens (in particular, testosterone) exert dual effects on mammary tumor development, with a proliferative effect mediated by the ER and an antiproliferative effect mediated by the androgen receptor [
         <a href="#rid51">
          51
         </a>
         ]. Elevated androgen (ie, testosterone) levels have been associated with an increased risk of postmenopausal and premenopausal breast cancer [
         <a href="#rid46">
          46,50,52
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Testosterone association with breast cancer subtypes has not been consistently seen. Some studies suggest that elevated testosterone levels increase the risk of breast cancer specifically for hormone receptor-positive breast cancers [
         <a href="#rid52">
          52-55
         </a>
         ], while one study suggests elevated testosterone levels are associated with a lower risk of hormone receptor-negative breast cancers [
         <a href="#rid49">
          49
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Insulin pathway and related factors
         </strong>
         – In reports from the Women's Health Initiative, higher insulin resistance levels were associated with higher breast cancer incidence (HR 1.34, 95% CI 1.12-1.61), as well as higher all-cause mortality and higher all-cancer-specific mortality [
         <a href="#rid56">
          56,57
         </a>
         ]. In addition, although diabetes is not considered a breast cancer risk factor [
         <a href="#rid58">
          58
         </a>
         ], a large pooled analysis drawing from 17 prospective studies suggested that insulin growth factor-1 was associated with breast cancer risk in both premenopausal and postmenopausal women [
         <a href="#rid59">
          59
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H1067591470">
         <span class="h2">
          Reproductive factors
         </span>
        </p>
        <p class="headingAnchor" id="H1252859098">
         <span class="h3">
          Earlier menarche or later menopause
         </span>
         <span class="headingEndMark">
          —
         </span>
         Early age at menarche is associated with a higher breast cancer risk [
         <a href="#rid21">
          21,60
         </a>
         ]. Women with menarche at or after 15 years of age were less likely to develop hormone receptor-positive breast cancer compared with women who experienced menarche before the age of 13 years (HR 0.76, 95% CI 0.68-0.85) [
         <a href="#rid21">
          21
         </a>
         ]. They also had a 16 percent lower risk of hormone receptor-negative breast cancer.
        </p>
        <p>
         In one study, for every one-year delay in the onset of menarche, breast cancer risk was 5 percent lower [
         <a href="#rid60">
          60
         </a>
         ]. In addition, later age at menopause is associated with higher breast cancer risk.
        </p>
        <p class="headingAnchor" id="H1688021201">
         <span class="h3">
          Nulliparity
         </span>
         <span class="headingEndMark">
          —
         </span>
         Nulliparous women are at higher risk for breast cancer compared with parous women (RR from 1.2 to 1.7) [
         <a href="#rid61">
          61,62
         </a>
         ]. Although parous women have an increased risk for developing breast cancer within the first few years of delivery relative to nulliparous women, parity confers a protective effect decades after delivery.
        </p>
        <p>
         Whether multiparity confers protection against breast cancer is controversial, because it is difficult to separate the effects of multiparity from early first full-term pregnancy; however, studies suggest a decreased risk with increasing number of pregnancies [
         <a href="#rid60">
          60,62,63
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H1792871071">
         <span class="h3">
          Increasing age at first full-term pregnancy
         </span>
         <span class="headingEndMark">
          —
         </span>
         The effect of parity also differs depending upon the age of first full-term birth. Women who become pregnant later in life have an increased risk of breast cancer [
         <a href="#rid60">
          60,62,63
         </a>
         ]. In the Nurses' Health Study, compared with nulliparous women at or near menopause, the cumulative incidence of breast cancer (up to age 70) was 20 percent lower among women who delivered their first child at age 20; 10 percent lower for those delivering their first child at age 25 years; and 5 percent higher among those delivering their first child at 35 years [
         <a href="#rid61">
          61
         </a>
         ]. The risk for a nulliparous woman of any age was similar to that of a woman with a first full-term birth at age 35.
        </p>
        <p>
         It has been proposed that full cellular differentiation, which occurs in the gland during and after pregnancy, protects the breast from breast cancer development [
         <a href="#rid64">
          64
         </a>
         ]. A later age at first birth may confer a greater risk than nulliparity because of the additional proliferative stimulation placed on breast cells that are more likely to be fully developed and perhaps more prone to cell damage.
        </p>
        <p>
         The relationship between infertility and breast cancer is controversial and is discussed below. (See
         <a class="local">
          'Infertility'
         </a>
         below.)
        </p>
        <p>
         In vitro fertilization does not appear to be associated with breast cancer risks. (See
         <a class="medical medical_review" href="/z/d/html/6788.html" rel="external">
          "Assisted reproductive technology: Pregnancy and maternal outcomes", section on 'Breast cancer'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H1067592185">
         <span class="h2">
          Personal and family history of breast cancer
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Personal history of breast cancer
         </strong>
         – A personal history of either invasive or in situ breast cancer increases the risk of developing an invasive breast cancer in the contralateral breast.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         A 2010 study using SEER data that included almost 340,000 women with a primary breast cancer found the incidence of invasive contralateral breast cancer (CBC) was 4 percent during an average follow-up of 7.5 years [
         <a href="#rid65">
          65
         </a>
         ]. The risk of a CBC varied by age at the time of the index breast cancer diagnosis (those &lt;30 years at diagnosis and those with ER-negative cancers were at higher risk; however, these rates have been decreasing over time, most likely due to advances in adjuvant breast cancer therapy).
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         In a separate study, risks of CBC among those with hormone receptor-positive breast cancer were approximately 0.2 percent per year for the first five years after diagnosis (during adjuvant endocrine therapy), 0.5 percent per year for the subsequent five years (after endocrine treatment), and somewhere between these estimates for the following 5 to 10 years [
         <a href="#rid66">
          66
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         In the setting of a personal history of breast cancer, a family history of breast cancer further increases CBC risk. For example, in a case-control study of women with CBC matched with women with unilateral breast cancer as controls, having a first-degree relative with breast cancer increased risk of CBC by almost twofold [
         <a href="#rid67">
          67
         </a>
         ]. Risks were further increased if the relative was diagnosed at age &lt;40 years.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Family history and genetic mutations
         </strong>
         – The risk associated with a positive family history of breast cancer is strongly affected by the number of female first-degree relatives with and without cancer, and the age when they were diagnosed.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         In a pooled analysis of over 50,000 women with breast cancer and 100,000 controls, the risk of breast cancer was [
         <a href="#rid68">
          68
         </a>
         ]:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Increased almost twofold if a woman had one affected first-degree relative
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Increased threefold if she had two affected first-degree relatives
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         The age at diagnosis of the affected first-degree relative also influences the risk for breast cancer [
         <a href="#rid68">
          68
         </a>
         ]. Women have a threefold higher risk if the first-degree relative was diagnosed before age 30 (RR 3.0, 95% CI 1.8-4.9), but the risk is only 1.5-fold higher if the affected relative was diagnosed after age 60. (See
         <a class="medical medical_review" href="/z/d/html/7564.html" rel="external">
          "Screening for breast cancer: Strategies and recommendations", section on 'Models predicting pathogenic BRCA1/2 mutations'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         However, family history is still an important risk factor even with relatives with a later age at diagnosis. In a prospective cohort study of over 400,000 women, family history of breast cancer in a first-degree relative was associated with a higher risk of breast cancer, regardless of whether the relative was diagnosed before or after 50 years of age [
         <a href="#rid69">
          69
         </a>
         ]. Criteria for genetic screening are discussed elsewhere. (See
         <a class="medical medical_review" href="/z/d/html/753.html" rel="external">
          "Genetic testing and management of individuals at risk of hereditary breast and ovarian cancer syndromes", section on 'Criteria for genetic risk evaluation'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Specific genetic mutations that predispose to breast cancer are rare; as an example, only approximately 6 percent of all breast cancers are directly attributable to inheritance of a
         <em>
          BRCA1/2
         </em>
         pathogenic variant. These and other variants are discussed in more detail elsewhere. (See
         <a class="medical medical_review" href="/z/d/html/758.html" rel="external">
          "Cancer risks and management of BRCA1/2 carriers without cancer"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/785.html" rel="external">
          "Overview of hereditary breast and ovarian cancer syndromes"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H2446695404">
         <span class="h2">
          Alcohol use and smoking
         </span>
         <span class="headingEndMark">
          —
         </span>
         Alcohol consumption is associated with a higher risk of breast cancer. This topic is discussed in detail elsewhere. (See
         <a class="medical medical_review" href="/z/d/html/2781.html" rel="external">
          "Overview of the risks and benefits of alcohol consumption", section on 'Breast cancer'
         </a>
         .)
        </p>
        <p>
        </p>
        <p>
         Although results have not been uniform, multiple studies suggest there is a modestly increased risk of breast cancer in smokers [
         <a href="#rid70">
          70-75
         </a>
         ]. For example, in a meta-analysis of 27 prospective observational studies, the risk of breast cancer was higher among women with any history of smoking (summary RR 1.10, 95% CI 1.02-1.14) [
         <a href="#rid70">
          70
         </a>
         ]. The relationship between cigarette smoking and breast cancer is complicated; as many as 50 percent of women who smoke also consume alcohol, a known breast cancer risk factor [
         <a href="#rid70">
          70
         </a>
         ]. However, even in women who did not drink alcohol, there was still a higher breast cancer risk associated with smoking [
         <a href="#rid70">
          70
         </a>
         ].
        </p>
        <p>
         Studies regarding passive smoking and breast cancer risk have been inconclusive, but evidence for an increase in risk with passive smoking is emerging [
         <a href="#rid72">
          72,76,77
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H1202896">
         <span class="h2">
          Exposure to therapeutic ionizing radiation
         </span>
         <span class="headingEndMark">
          —
         </span>
         Exposure to ionizing radiation of the chest at a young age, as occurs with treatment of Hodgkin lymphoma or in survivors of atomic bomb or nuclear plant accidents, is associated with an increased risk of breast cancer [
         <a href="#rid78">
          78-80
         </a>
         ]. The most vulnerable ages appear to be between 10 to 14 years (prepuberty), although excess risk is seen in women exposed as late as 45 years of age [
         <a href="#rid81">
          81
         </a>
         ]. After age 45, risk is attenuated. (See
         <a class="medical medical_review" href="/z/d/html/4764.html" rel="external">
          "Second malignancies after treatment of classic Hodgkin lymphoma"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H1202177">
         <span class="h1">
          FACTORS ASSOCIATED WITH DECREASED BREAST CANCER RISK
         </span>
        </p>
        <p class="headingAnchor" id="H893703629">
         <span class="h2">
          Medical and surgical risk reduction strategies
         </span>
         <span class="headingEndMark">
          —
         </span>
         Chemoprevention with aromatase inhibitors in postmenopausal women, or
         <a class="drug drug_general" data-topicid="9972" href="/z/d/drug information/9972.html" rel="external">
          tamoxifen
         </a>
         in pre- or postmenopausal women, reduces breast cancer risks. Mastectomy also greatly decreases breast cancer risks, and is an appropriate option for select patients at high risk, for example
         <em>
          BRCA
         </em>
         carriers. These strategies, as well as appropriate candidates, are discussed in detail elsewhere. (See
         <a class="medical medical_review" href="/z/d/html/758.html" rel="external">
          "Cancer risks and management of BRCA1/2 carriers without cancer"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/785.html" rel="external">
          "Overview of hereditary breast and ovarian cancer syndromes"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/756.html" rel="external">
          "Selective estrogen receptor modulators and aromatase inhibitors for breast cancer prevention"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/94744.html" rel="external">
          "Contralateral prophylactic mastectomy"
         </a>
         .)
        </p>
        <p>
         The effect of oophorectomy on breast cancer risk in the general population and among
         <em>
          BRCA
         </em>
         carriers is discussed elsewhere. (See
         <a class="medical medical_review" href="/z/d/html/14198.html" rel="external">
          "Elective oophorectomy or ovarian conservation at the time of hysterectomy"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/758.html" rel="external">
          "Cancer risks and management of BRCA1/2 carriers without cancer", section on 'Bilateral salpingo-oophorectomy'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H1202289">
         <span class="h2">
          Breastfeeding
         </span>
         <span class="headingEndMark">
          —
         </span>
         A protective effect of breastfeeding has been shown in multiple case-control and cohort studies and meta-analyses, the magnitude of which depends on the duration of breastfeeding and on the confounding factor of parity [
         <a href="#rid82">
          82,83
         </a>
         ].
        </p>
        <p>
         A large pooled analysis that included individual data from 47 epidemiologic studies (approximately 50,000 women with invasive breast cancer and 97,000 controls) estimated that for every 12 months of breastfeeding, there was a 4.3 percent reduction in the relative risk (RR) of breast cancer [
         <a href="#rid82">
          82
         </a>
         ]. Another meta-analysis suggested that this association was stronger for hormone receptor-negative breast cancers [
         <a href="#rid83">
          83
         </a>
         ]. A postulated mechanism for the protective effect of breastfeeding is that it may delay the re-establishment of ovulatory cycles.
        </p>
        <p class="headingAnchor" id="H1202338">
         <span class="h2">
          Physical activity
         </span>
         <span class="headingEndMark">
          —
         </span>
         While there is no prospective clinical trial evidence, the observational studies strongly suggest that physical activity is associated with lower breast cancer risk [
         <a href="#rid84">
          84-86
         </a>
         ]. A 2016 review of epidemiologic studies estimated that risk of breast cancer was lower among the most physically active women compared with the least active women (RR 0.88, 95% CI 0.85-0.90) [
         <a href="#rid84">
          84
         </a>
         ]. Another meta-analysis of 139 prospective and retrospective studies evaluated physical activity and weight loss in approximately 237,000 breast cancer cases and 4 million controls. Higher physical activity levels were associated with lower breast cancer risk (odds ratio [OR] 0.78, 95% CI 0.76-0.81). The findings were similar in pre-and postmenopausal women and for light- and high-intensity physical activity [
         <a href="#rid87">
          87
         </a>
         ].
        </p>
        <p>
         Given the paradoxical effect of weight in premenopausal and postmenopausal women, the reduction in breast cancer risk seen with exercise is likely not mediated through weight control alone [
         <a href="#rid88">
          88-91
         </a>
         ]. Increased physical activity may reduce breast cancer risk through hormonal influences such as reducing serum estrogens, insulin, and insulin growth factor-1 levels [
         <a href="#rid92">
          92-94
         </a>
         ]. (See
         <a class="local">
          'Weight loss in postmenopausal women'
         </a>
         below and
         <a class="local">
          'Low-fat dietary pattern in postmenopausal women'
         </a>
         below and
         <a class="local">
          'Hormonal factors'
         </a>
         above.)
        </p>
        <p class="headingAnchor" id="H1412664726">
         <span class="h2">
          Weight loss in postmenopausal women
         </span>
         <span class="headingEndMark">
          —
         </span>
         While not seen in all studies [
         <a href="#rid13">
          13,95
         </a>
         ], weight loss in postmenopausal women may reduce breast cancer risk [
         <a href="#rid8">
          8,87,96-101
         </a>
         ], as observed in the examples below:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         In the meta-analysis of prospective and retrospective studies discussed above, including approximately 237,000 cases and 4 million controls, weight loss was associated with lower breast cancer risk (OR 0.82, 95% CI 0.67-0.97) [
         <a href="#rid87">
          87
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Among prospective studies, the Nurse's Health Study assessed weight change since menopause among approximately 50,000 women followed for up to 24 years. Women with no prior hormone therapy use who maintained a weight loss of ≥10 kg were at lower breast cancer risk than women who did not (RR 0.43, 95% CI 0.21-0.86) [
         <a href="#rid8">
          8
         </a>
         ]. More recently, in roughly 61,000 postmenopausal women in the Women's Health Initiative (WHI), those who lost ≥5 percent of body weight in the three years from study entry had a lower breast cancer incidence over a mean of 11.4 years compared with women who did not (hazard ratio [HR] 0.88, 95% CI 0.78-0.98) [
         <a href="#rid96">
          96
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Retrospective studies have shown similar results. Among almost 34,000 participants in the Iowa Women's Health Study reporting recalled weight over a 35 year period, those with intentional weight loss ≥20 pounds had lower breast cancer risk (RR 0.81, 95% CI 0.66-1.00) [
         <a href="#rid100">
          100
         </a>
         ], with similar significant findings in a subsequent analysis (RR 0.77, 95% CI 0.55-0.93) [
         <a href="#rid99">
          99
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H2493746790">
         <span class="h2">
          Low-fat dietary pattern in postmenopausal women
         </span>
         <span class="headingEndMark">
          —
         </span>
         The low-fat eating pattern involves dietary moderation, and is similar to the Dietary Approaches to Stop Hypertension diet, but with somewhat more emphasis on fat intake reduction [
         <a href="#rid102">
          102,103
         </a>
         ]. This pattern has been associated with reducing deaths following breast cancer diagnosis [
         <a href="#rid104">
          104
         </a>
         ], with potential mediating mechanisms including reducing metabolic syndrome components and estradiol [
         <a href="#rid13">
          13,105
         </a>
         ].
        </p>
        <p>
         The WHI Dietary Modification trial randomly assigned almost 49,000 postmenopausal women with no previous breast cancer to a usual diet comparison group or a low-fat dietary pattern, with every-three-week group sessions in the first year, and quarterly maintenance sessions throughout the 8.5-year intervention period [
         <a href="#rid105">
          105,106
         </a>
         ]. The dietary intervention reduced fat intake to 24 percent calories from fat, and increased the intake of fruit, vegetables, and grains, resulting in modest weight loss (3 percent). After cumulative follow-up of nearly 20 years, the dietary group experienced fewer deaths from breast cancer (0.037 versus 0.047 percent; HR 0·79, 95% CI 0·64-0·97). This finding did not change by addition of time-dependent weight change and was mediated, in part, by a reduction in poor prognosis, estrogen receptor-positive, progesterone receptor-negative breast cancers (HR 0.77, 95% CI 0.64-0.94).
        </p>
        <p>
         The influence of dietary fat, as a single component of diet, on breast cancer risks is discussed below. (See
         <a class="local">
          'Other dietary factors'
         </a>
         below.)
        </p>
        <p class="headingAnchor" id="H1738673851">
         <span class="h1">
          INCONCLUSIVE FACTORS
         </span>
        </p>
        <p class="headingAnchor" id="H1344977160">
         <span class="h2">
          Diet rich in fruits and vegetables, fish, and olive oil (eg, Mediterranean diet)
         </span>
         <span class="headingEndMark">
          —
         </span>
         A Mediterranean diet, characterized by an abundance of plant foods, fish, and olive oil, may decrease breast cancer risk, but further study is needed.
        </p>
        <p>
         In one clinical trial, almost 4300 women aged 60 to 80 years were randomly assigned to a Mediterranean diet supplemented with extra-virgin olive oil, a Mediterranean diet supplemented with mixed nuts, or a control diet with a primary outcome of cardiovascular disease [
         <a href="#rid107">
          107
         </a>
         ]. Over 4.8 years of follow-up, there were 35 cases of breast cancer (33 of which were hormone receptor positive). There were fewer breast cancer cases in the Mediterranean diet supplemented with olive oil versus the control group (hazard ratio [HR] 0.32, 95% CI 0.13-0.79). Limitations include small event number and an absence of mammography information. Thus, findings would need to be confirmed in a larger study.
        </p>
        <p>
         Studies have been conflicting in regards to whether a Mediterranean diet is associated with a decrease in incidence of all breast cancer, or estrogen receptor (ER)-negative breast cancers only.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         In a systematic review, three of four cohort studies examining Mediterranean diet adherence and breast cancer showed inverse associations with postmenopausal ER-negative, but not ER-positive, breast cancers [
         <a href="#rid108">
          108
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         In the same time frame, a meta-analysis of five cohort studies examining Mediterranean diet and breast cancer in postmenopausal women found a 6 percent lower risk for all breast cancers, which was of borderline significance (relative risk [RR] 0.94, 95% CI 0.88-1.01) [
         <a href="#rid109">
          109
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         In the Nurses' Health Study, the association of alternate Mediterranean Diet score (aMed) with breast cancer risk was examined [
         <a href="#rid110">
          110
         </a>
         ]. With 3580 cases of breast cancer, the highest quintile of aMed was associated with similar rates of total and ER-positive breast cancer to the lowest quintile, but lower rates of ER-negative breast cancer.
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H527771866">
         <span class="h2">
          Other dietary factors
         </span>
         <span class="headingEndMark">
          —
         </span>
         With rare exception, data gathered largely from observational studies suggest that certain dietary factors may modify breast cancer risk. However, methodologic issues regarding the measurement of nutritional intake and the contribution of other factors (eg, alcohol use) complicate these analyses and the interpretation of studies. The concept of studies designed to evaluate foods and/or nutrients in isolation is being challenged by the concept that evaluation of overall dietary patterns may better reflect the nature of the actual dietary exposure in a population [
         <a href="#rid111">
          111
         </a>
         ]. Information regarding dietary patterns and breast cancer risk is found above. (See
         <a class="local">
          'Low-fat dietary pattern in postmenopausal women'
         </a>
         above and
         <a class="local">
          'Diet rich in fruits and vegetables, fish, and olive oil (eg, Mediterranean diet)'
         </a>
         above.)
        </p>
        <p>
         A summary of what is known about specific dietary factors and breast cancer risk is discussed below.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Fruits and vegetables
         </strong>
         – Data regarding the contribution of fruits and vegetables on breast cancer risk are inconclusive, with some evidence suggesting no effect and other studies suggesting a lower breast cancer risk in women with higher fruit and vegetable intakes.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         In a prospective study of over 993,000 women observed for 11 to 20 years, no association between total fruit and vegetable intake and overall risk of breast cancer was identified [
         <a href="#rid112">
          112
         </a>
         ]. However, other studies have suggested a decreased breast cancer risk in diets high in fruits and vegetables [
         <a href="#rid105">
          105,113-115
         </a>
         ]. A 2010 meta-analysis of studies evaluating breast cancer risk reported that high consumption of a diet composed predominantly of fruits and vegetables was associated with lower breast cancer risk (odds ratio [OR] 0.89, 95% CI 0.82-0.99) [
         <a href="#rid114">
          114
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Randomized clinical trials incorporating a pattern of increased fruits and vegetables are discussed above. (See
         <a class="local">
          'Low-fat dietary pattern in postmenopausal women'
         </a>
         above and
         <a class="local">
          'Diet rich in fruits and vegetables, fish, and olive oil (eg, Mediterranean diet)'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Fat intake
         </strong>
         – Observational studies evaluating dietary fat intake as a single dietary component provide inconsistent results regarding breast cancer risk [
         <a href="#rid116">
          116
         </a>
         ]. However, a low-fat dietary pattern including increase in fruit, vegetables, and grains may reduce breast cancer mortality, as discussed above [
         <a href="#rid105">
          105
         </a>
         ]. (See
         <a class="local">
          'Low-fat dietary pattern in postmenopausal women'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         A meta-analysis of cohort studies found no significant association between dietary fat intake and breast cancer risk (RR 1.03, 95% CI 0.76-1.40) [
         <a href="#rid116">
          116
         </a>
         ]. However, in the AARP Diet and Health Study, women in the highest fat intake quintile had breast cancer rates 11 to 22 percent higher compared with women in the lowest quintile [
         <a href="#rid117">
          117
         </a>
         ]. In a more recent meta-analysis of 15 prospective cohort studies evaluating dietary fat and breast cancer mortality, breast cancer-specific death was higher for women with the highest compared with lowest saturated fat intake (HR 1.5, 95% CI 1.09-2.09; p &lt;0.01), but there is no such association with total fat intake [
         <a href="#rid118">
          118
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         These inconsistent results could reflect limitations of the dietary assessment methodology [
         <a href="#rid119">
          119
         </a>
         ]. In this regard, one study found dietary fat intake significantly associated with breast cancer incidence only when intake was based on food diaries rather than the food frequency questionnaires most commonly used in observational studies [
         <a href="#rid120">
          120
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/4555.html" rel="external">
          "Dietary fat", section on 'Cancer'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Soy/phytoestrogens
         </strong>
         – Phytoestrogens are naturally occurring plant substances with a chemical structure similar to 17-beta estradiol. They consist mainly of isoflavones (found in high concentrations in soybeans and other legumes) and lignans (found in a variety of fruits, vegetables, and cereal products). There is only low-quality evidence that soy-rich diets in Western women prevent breast cancer.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         A 2014 meta-analysis of eight studies evaluating the impact of soy food intake and breast cancer risk reported the following results [
         <a href="#rid121">
          121
         </a>
         ]: pooled studies in Asian countries suggested that soy isoflavone has a protective effect in both pre- and postmenopausal women (OR 0.59, 95% CI 0.48-0.69; OR 0.59, 95% CI 0.44-0.74, respectively). Pooled studies on postmenopausal women in Western countries found that soy isoflavone intake has only a marginally protective effect (OR 0.92, 95% CI 0.83-1.00). However, further analyses stratifying by study design found no statistically significant association.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Red meat and processed meat
         </strong>
         – Red meat and processed meat have been suggested to increase breast cancer risk, but data are inconclusive. Two meta analyses found processed meat to be associated with higher breast cancer incidence, but there was no observed association with red meat [
         <a href="#rid122">
          122,123
         </a>
         ]. In the 2010 meta-analysis discussed above, there was no influence on the risk of breast cancer among women who reported a high intake of a diet rich in red/processed meats. Meanwhile, an association between intake of red meat (&gt;5 servings per week) and premenopausal breast cancer has been reported in a few studies, but the evidence linking this to breast cancer risk is weaker than that for other cancers [
         <a href="#rid124">
          124-126
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         The suggested relationship has been based on iron content, estrogen use as a supplement for cattle, and mutagens created by cooking. However, further data are needed.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Fiber intake
         </strong>
         – In a meta-analysis of 24 epidemiologic studies, dietary fiber intake was associated with a 12 percent relative risk reduction in breast cancer incidence, with dose-response analysis suggesting that every 10 gram/day increment in dietary fiber intake was associated with a 4 percent relative risk reduction in breast cancer [
         <a href="#rid127">
          127
         </a>
         ]. However, randomized trials are necessary to confirm this finding.
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H2446696293">
         <span class="h2">
          Geographic residence
         </span>
         <span class="headingEndMark">
          —
         </span>
         Globally, breast cancer is the most frequently diagnosed cancer and the leading cause of cancer death in females. Breast cancer incidence rates are highest in North America, Australia/New Zealand, and in western and northern Europe and lowest in Asia and sub-Saharan Africa [
         <a href="#rid1">
          1
         </a>
         ]. Despite the decreases in incidence rates in North America, breast cancer incidence has been increasing in other parts of the world, such as Asia and Africa. These international differences are thought to be related to societal changes occurring during industrialization (eg, changes in fat intake, body weight, age at menarche, and/or lactation and reproductive patterns such as fewer pregnancies and later age at first birth).
        </p>
        <p>
         Even within the United States, the breast cancer risk varies substantially among regions. Geographic cluster regions with high breast cancer incidence rates have been identified, such as Cape Cod, Massachusetts; Long Island, New York; and Marin County, California [
         <a href="#rid128">
          128-130
         </a>
         ]. These clusters are most likely due to regional differences in established breast cancer risk factors, but studies are ongoing to better understand these clusters [
         <a href="#rid131">
          131
         </a>
         ]. Studies of migration patterns of women from low-risk areas to the United States are consistent with the importance of cultural and/or environmental changes [
         <a href="#rid132">
          132
         </a>
         ]. In general, incidence rates of breast cancer are greater in second-generation migrants and increase further in third- and fourth-generation migrants.
        </p>
        <p class="headingAnchor" id="H2446696300">
         <span class="h2">
          Exposure to diagnostic radiation
         </span>
         <span class="headingEndMark">
          —
         </span>
         Whether there is a link between breast cancer risk and diagnostic levels of irradiation (eg, mammography, chest radiographs, diagnostic spine imaging, computed tomography scans) in women without an inherited predisposition is controversial [
         <a href="#rid133">
          133-135
         </a>
         ]. However, the risk of breast cancer associated with diagnostic radiation in women with an inherited
         <em>
          BRCA1/2
         </em>
         mutation appears to be increased [
         <a href="#rid136">
          136-138
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/87311.html" rel="external">
          "Screening for breast cancer: Evidence for effectiveness and harms", section on 'Radiation'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H9305001">
         <span class="h2">
          Medications
         </span>
         <span class="headingEndMark">
          —
         </span>
         Several medication classes may have a modifying effect on breast cancer risk. However, the evidence to support their association to breast cancer is weak. These include the following:
        </p>
        <p class="headingAnchor" id="H9305250">
         <span class="h3">
          Calcium/vitamin D
         </span>
         <span class="headingEndMark">
          —
         </span>
         Although observational studies have suggested that higher plasma 25-hydroxyvitamin D levels may be associated with lower breast cancer risk in postmenopausal (but not premenopausal) women [
         <a href="#rid139">
          139
         </a>
         ], randomized trials of vitamin D supplementation have not shown a protective effect [
         <a href="#rid140">
          140
         </a>
         ].
        </p>
        <p>
         In a Women's Health Initiative (WHI) randomized trial, among over 36,000 postmenopausal women, those assigned to 1000 mg of elemental calcium with 400 international units (IU) of
         <a class="drug drug_general" data-topicid="10117" href="/z/d/drug information/10117.html" rel="external">
          vitamin D3
         </a>
         did not have higher rates of invasive breast cancer relative to placebo, during the seven years of intervention and 4.9 years of post-intervention follow-up [
         <a href="#rid141">
          141,142
         </a>
         ]. Similarly, the randomized
         <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.clinicaltrials.gov%2Fct2%2Fshow%2FNCT01169259&amp;token=Rti1NBSWdX%2F%2FH%2FlCKGrzlGu03gYcMJXuTK3xOgZRWSzsJf3If9Fs1BlUGXQoEBcWNyAU%2B9OuSHKgsoD4S66tDg%3D%3D&amp;TOPIC_ID=792" target="_blank">
          VITAL trial
         </a>
         of over 25,000 men and women found no significant effect of vitamin D (2000 IU) with or without omega-3 supplements on breast cancer incidence, or on total invasive cancer and major cardiovascular disease events (the coprimary study outcomes) [
         <a href="#rid143">
          143,144
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H9305267">
         <span class="h3">
          Nonsteroidal anti-inflammatory drugs
         </span>
         <span class="headingEndMark">
          —
         </span>
         The data regarding a possible protective effect of nonsteroidal anti-inflammatory drugs (NSAIDs) on breast cancer risk are mixed:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         A meta-analysis of 49 studies concluded that use of any NSAID was associated with a lower breast cancer risk of approximately 20 percent (OR 0.82, 95% CI 0.77-0.88), with similar findings for
         <a class="drug drug_general" data-topicid="8907" href="/z/d/drug information/8907.html" rel="external">
          aspirin
         </a>
         ,
         <a class="drug drug_general" data-topicid="9242" href="/z/d/drug information/9242.html" rel="external">
          acetaminophen
         </a>
         , cyclooxygenase-2 inhibitors, and, to a lesser extent,
         <a class="drug drug_general" data-topicid="8547" href="/z/d/drug information/8547.html" rel="external">
          ibuprofen
         </a>
         [
         <a href="#rid145">
          145
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         However, a 2012 report from the Nurses' Health Study found no association between the use of
         <a class="drug drug_general" data-topicid="8907" href="/z/d/drug information/8907.html" rel="external">
          aspirin
         </a>
         , NSAIDs, or
         <a class="drug drug_general" data-topicid="9242" href="/z/d/drug information/9242.html" rel="external">
          acetaminophen
         </a>
         and the incidence of breast cancer (overall or by hormone receptor status) [
         <a href="#rid146">
          146
         </a>
         ]. In addition, in the only randomized trial in which the impact of low-dose aspirin (100 mg every other day) on cancer prevention was evaluated, no effect on breast cancer or total cancer was seen after an average of 10 years of follow-up [
         <a href="#rid147">
          147
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H9305274">
         <span class="h3">
          Bisphosphonates
         </span>
         <span class="headingEndMark">
          —
         </span>
         Oral bisphosphonates are commonly used for the treatment of osteoporosis and for women with breast cancer with evidence of bone loss attributed to aromatase inhibitors. Whether their use is a true protective factor for those without a history of breast cancer is unclear. (See
         <a class="medical medical_review" href="/z/d/html/2030.html" rel="external">
          "Bisphosphonate therapy for the treatment of osteoporosis"
         </a>
         .)
        </p>
        <p>
         Although some studies have shown a decreased risk of breast cancer with bisphosphonates by approximately one-third [
         <a href="#rid148">
          148-151
         </a>
         ], other studies, including a large observational cohort of over 64,000 postmenopausal women followed for approximately seven years, have not seen an association [
         <a href="#rid152">
          152
         </a>
         ]. Low bone mineral density may reflect a lower-estrogen environment, so the decreased risk observed with bisphosphonates in some studies may reflect a population that is at lower risk of getting breast cancer. (See
         <a class="local">
          'Bone mineral density'
         </a>
         above.)
        </p>
        <p>
         The protective effect of bisphosphonates in the adjuvant setting of women diagnosed with breast cancer is an ongoing area of research. (See
         <a class="medical medical_review" href="/z/d/html/776.html" rel="external">
          "Use of osteoclast inhibitors in early breast cancer"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H3952258797">
         <span class="h2">
          Phthalates
         </span>
         <span class="headingEndMark">
          —
         </span>
         Phthalates are chemicals found in medical supplies, food containers, cosmetics, toys, and medications, particularly those with suspended-release formulations [
         <a href="#rid153">
          153,154
         </a>
         ]. They have been reported to have hormonal effects [
         <a href="#rid155">
          155
         </a>
         ], but the effect on breast cancer risk is still unclear. For example, in a nested case-control study of postmenopausal participants in the prospective WHI, there was no association between urinary metabolites of phthalates and breast cancer incidence [
         <a href="#rid156">
          156
         </a>
         ]. However, in a nationwide Danish cohort study of women at risk for cancer, high levels of phthalate exposure from medications (≥10,000 cumulative mg, calculated from prescriptions filled) was associated with an approximately twofold increase in the rate of ER-positive breast cancer (but not ER-negative breast cancer) [
         <a href="#rid157">
          157
         </a>
         ]. The association was stronger among premenopausal women. At this point, more conclusive data are needed to determine whether high-level exposure, as through long-term use of phthalate-containing medications, is a breast cancer risk factor.
        </p>
        <p class="headingAnchor" id="H2618324342">
         <span class="h2">
          Infertility
         </span>
         <span class="headingEndMark">
          —
         </span>
         The association between infertility and breast cancer risk is controversial. Several epidemiologic studies suggest that infertility due to anovulatory disorders decreases the risk of breast cancer [
         <a href="#rid63">
          63,158,159
         </a>
         ]. However, other studies have observed either no association or a slight increase in risk associated with infertility after adjusting for prior pregnancy history and age at first delivery [
         <a href="#rid158">
          158,160
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H4132025241">
         <span class="h2">
          Night-shift work
         </span>
         <span class="headingEndMark">
          —
         </span>
         Night-shift work is recognized by the International Agency for Research on Cancer and the World Health Organization as a probable carcinogen [
         <a href="#rid161">
          161
         </a>
         ], although evidence is mixed [
         <a href="#rid161">
          161-164
         </a>
         ]. This association may be related to nocturnal light exposure, which results in the suppression of nocturnal melatonin production by the pineal gland [
         <a href="#rid165">
          165
         </a>
         ]. Evidence to support this comes from the finding that low levels of 6-sulfatoxymelatonin (the major melatonin metabolite) are associated with an increased risk of breast cancer [
         <a href="#rid165">
          165,166
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/97868.html" rel="external">
          "Pharmacotherapy for insomnia in adults", section on 'Melatonin'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H9304529">
         <span class="h1">
          FACTORS THAT DO NOT INFLUENCE BREAST CANCER RISK
         </span>
        </p>
        <p class="headingAnchor" id="H9304554">
         <span class="h2">
          Abortion
         </span>
         <span class="headingEndMark">
          —
         </span>
         Both a large pooled analysis [
         <a href="#rid167">
          167
         </a>
         ] and population-based cohort studies [
         <a href="#rid168">
          168-172
         </a>
         ] do not support an association between abortion (induced or spontaneous) and breast cancer risk. The effect of age of first full-term birth is discussed above. (See
         <a class="local">
          'Increasing age at first full-term pregnancy'
         </a>
         above.)
        </p>
        <p class="headingAnchor" id="H106517721">
         <span class="h2">
          Chemicals
         </span>
         <span class="headingEndMark">
          —
         </span>
         Organochlorines include polychlorinated biphenyls, dioxins, and organochlorine pesticides such as dichlorodiphenyltrichloroethane. These compounds are weak estrogens, highly lipophilic, and capable of persisting in body tissues for years. However, an association with breast cancer has not been demonstrated [
         <a href="#rid173">
          173,174
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H1185476246">
         <span class="h2">
          Antioxidants
         </span>
         <span class="headingEndMark">
          —
         </span>
         There is no evidence for an effect of intake of
         <a class="drug drug_general" data-topicid="10047" href="/z/d/drug information/10047.html" rel="external">
          vitamin A
         </a>
         , E, or C or
         <a class="drug drug_general" data-topicid="9127" href="/z/d/drug information/9127.html" rel="external">
          beta-carotene
         </a>
         on breast cancer risk [
         <a href="#rid175">
          175,176
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H4621386">
         <span class="h2">
          Tubal ligation
         </span>
         <span class="headingEndMark">
          —
         </span>
         Early observational studies reported inconsistent results on the association between tubal ligation and breast cancer risk. A meta-analysis of 77,249 postmenopausal, cancer-free women found no association between tubal ligation and breast cancer risk (odds ratio 0.97, 95% CI 0.84-1.09) [
         <a href="#rid177">
          177
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H1202777">
         <span class="h2">
          Caffeine
         </span>
         <span class="headingEndMark">
          —
         </span>
         A number of studies have failed to show any association between caffeine intake and breast cancer risk [
         <a href="#rid178">
          178,179
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/5369.html" rel="external">
          "Benefits and risks of caffeine and caffeinated beverages"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H86339679">
         <span class="h2">
          Other
         </span>
         <span class="headingEndMark">
          —
         </span>
         Well-done epidemiologic studies have failed to find any association between cosmetic breast implants, electromagnetic fields, electric blankets, and hair dyes and breast cancer risk [
         <a href="#rid174">
          174,180
         </a>
         ].
        </p>
        <p>
         For women undergoing in vitro fertilization, there does not appear to be an increased long-term risk of breast cancer. This is discussed in detail elsewhere. (See
         <a class="medical medical_review" href="/z/d/html/6788.html" rel="external">
          "Assisted reproductive technology: Pregnancy and maternal outcomes", section on 'Breast cancer'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H2446697312">
         <span class="h1">
          INFORMATION FOR PATIENTS
         </span>
         <span class="headingEndMark">
          —
         </span>
         UpToDate offers two types of patient education materials, "The Basics" and "Beyond the Basics." The Basics patient education pieces are written in plain language, at the 5
         <sup>
          th
         </sup>
         to 6
         <sup>
          th
         </sup>
         grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10
         <sup>
          th
         </sup>
         to 12
         <sup>
          th
         </sup>
         grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.
        </p>
        <p>
         Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on "patient info" and the keyword(s) of interest.)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Beyond the Basics topics (see
         <a class="medical medical_patient" href="/z/d/html/875.html" rel="external">
          "Patient education: Factors that affect breast cancer risk in women (Beyond the Basics)"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H2446697319">
         <span class="h1">
          SUMMARY
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Non-modifiable risk factors for breast cancer
         </strong>
         – Non-modifiable factors associated with higher breast cancer risk include increasing age, female sex, white race, family history, certain genetic alterations, breast atypia, and dense breast tissue. (See
         <a class="local">
          'Factors associated with greater breast cancer risk'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Reproductive risk factors
         </strong>
         – Reproductive factors that increase breast cancer risk include early menarche, later age at the time of first pregnancy (&gt;35 years old), absence of breastfeeding, and nulliparity. (See
         <a class="local">
          'Reproductive factors'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Modifiable risk factors
         </strong>
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         For postmenopausal women, obesity is associated with a higher breast cancer risk, which is ameliorated by weight loss. However, a higher body mass index has been associated with a lower risk of breast cancer in premenopausal women. (See
         <a class="local">
          'Weight and body fat in postmenopausal women'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Combined estrogen/progesterone menopausal hormone therapy in women with intact uteri has been clearly shown to increase risk of subsequent estrogen receptor-positive breast cancer. However, in women with prior hysterectomy, single-agent estrogen replacement has not been associated with increased risk of breast cancer (and is actually associated with reduced risks). (See
         <a class="medical medical_review" href="/z/d/html/7392.html" rel="external">
          "Menopausal hormone therapy and the risk of breast cancer"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Alcohol use and current smoking are associated with a higher risks of breast cancer. (See
         <a class="local">
          'Alcohol use and smoking'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         A low-fat dietary pattern, which includes increase in fruits, vegetables, and grains, may reduce risk of death from breast cancer in postmenopausal women. (See
         <a class="local">
          'Other dietary factors'
         </a>
         above and
         <a class="local">
          'Low-fat dietary pattern in postmenopausal women'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Regular, moderate physical activity may provide modest protection against breast cancer. (See
         <a class="local">
          'Physical activity'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Factors that do not influence breast cancer risk
         </strong>
         – A number of other variables, including abortion, caffeine intake, in vitro fertilization, cosmetic breast implants, and hair dyes are not associated with increased risks of breast cancer. (See
         <a class="local">
          'Factors that do not influence breast cancer risk'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H181100705">
         <span class="h1">
          ACKNOWLEDGMENT
         </span>
         <span class="headingEndMark">
          —
         </span>
         The UpToDate editorial staff acknowledges Wendy Y Chen, MD, MPH, who contributed to an earlier version of this topic review.
        </p>
       </div>
       <div class="headingAnchor" id="references">
        <ol id="reference">
         <li>
          <a class="nounderline abstract_t">
           Sung H, Ferlay J, Siegel RL, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin 2021; 71:209.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer Statistics, 2021. CA Cancer J Clin 2021; 71:7.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chlebowski RT, Chen Z, Anderson GL, et al. Ethnicity and breast cancer: factors influencing differences in incidence and outcome. J Natl Cancer Inst 2005; 97:439.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Richardson LC, Henley SJ, Miller JW, et al. Patterns and Trends in Age-Specific Black-White Differences in Breast Cancer Incidence and Mortality - United States, 1999-2014. MMWR Morb Mortal Wkly Rep 2016; 65:1093.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Carey LA, Perou CM, Livasy CA, et al. Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study. JAMA 2006; 295:2492.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Apovian CM. Obesity: definition, comorbidities, causes, and burden. Am J Manag Care 2016; 22:s176.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lahmann PH, Hoffmann K, Allen N, et al. Body size and breast cancer risk: findings from the European Prospective Investigation into Cancer And Nutrition (EPIC). Int J Cancer 2004; 111:762.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Eliassen AH, Colditz GA, Rosner B, et al. Adult weight change and risk of postmenopausal breast cancer. JAMA 2006; 296:193.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Morimoto LM, White E, Chen Z, et al. Obesity, body size, and risk of postmenopausal breast cancer: the Women's Health Initiative (United States). Cancer Causes Control 2002; 13:741.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lauby-Secretan B, Scoccianti C, Loomis D, et al. Body Fatness and Cancer--Viewpoint of the IARC Working Group. N Engl J Med 2016; 375:794.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Keum N, Greenwood DC, Lee DH, et al. Adult weight gain and adiposity-related cancers: a dose-response meta-analysis of prospective observational studies. J Natl Cancer Inst 2015; 107.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Key TJ, Appleby PN, Reeves GK, et al. Body mass index, serum sex hormones, and breast cancer risk in postmenopausal women. J Natl Cancer Inst 2003; 95:1218.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Neuhouser ML, Aragaki AK, Prentice RL, et al. Overweight, Obesity, and Postmenopausal Invasive Breast Cancer Risk: A Secondary Analysis of the Women's Health Initiative Randomized Clinical Trials. JAMA Oncol 2015; 1:611.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gunter MJ, Hoover DR, Yu H, et al. Insulin, insulin-like growth factor-I, and risk of breast cancer in postmenopausal women. J Natl Cancer Inst 2009; 101:48.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chlebowski RT, Anderson GL, Aragaki AK, et al. Association of Menopausal Hormone Therapy With Breast Cancer Incidence and Mortality During Long-term Follow-up of the Women's Health Initiative Randomized Clinical Trials. JAMA 2020; 324:369.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Nelson HD, Zakher B, Cantor A, et al. Risk factors for breast cancer for women aged 40 to 49 years: a systematic review and meta-analysis. Ann Intern Med 2012; 156:635.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Premenopausal Breast Cancer Collaborative Group, Schoemaker MJ, Nichols HB, et al. Association of Body Mass Index and Age With Subsequent Breast Cancer Risk in Premenopausal Women. JAMA Oncol 2018; 4:e181771.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ahlgren M, Melbye M, Wohlfahrt J, Sørensen TI. Growth patterns and the risk of breast cancer in women. N Engl J Med 2004; 351:1619.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Green J, Cairns BJ, Casabonne D, et al. Height and cancer incidence in the Million Women Study: prospective cohort, and meta-analysis of prospective studies of height and total cancer risk. Lancet Oncol 2011; 12:785.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           van den Brandt PA, Spiegelman D, Yaun SS, et al. Pooled analysis of prospective cohort studies on height, weight, and breast cancer risk. Am J Epidemiol 2000; 152:514.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ritte R, Lukanova A, Tjønneland A, et al. Height, age at menarche and risk of hormone receptor-positive and -negative breast cancer: a cohort study. Int J Cancer 2013; 132:2619.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           McCormack VA, dos Santos Silva I. Breast density and parenchymal patterns as markers of breast cancer risk: a meta-analysis. Cancer Epidemiol Biomarkers Prev 2006; 15:1159.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Boyd NF, Guo H, Martin LJ, et al. Mammographic density and the risk and detection of breast cancer. N Engl J Med 2007; 356:227.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Boyd NF, Rommens JM, Vogt K, et al. Mammographic breast density as an intermediate phenotype for breast cancer. Lancet Oncol 2005; 6:798.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wong CS, Lim GH, Gao F, et al. Mammographic density and its interaction with other breast cancer risk factors in an Asian population. Br J Cancer 2011; 104:871.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Advani SM, Zhu W, Demb J, et al. Association of Breast Density With Breast Cancer Risk Among Women Aged 65 Years or Older by Age Group and Body Mass Index. JAMA Netw Open 2021; 4:e2122810.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kerlikowske K, Ichikawa L, Miglioretti DL, et al. Longitudinal measurement of clinical mammographic breast density to improve estimation of breast cancer risk. J Natl Cancer Inst 2007; 99:386.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Jiang S, Bennett DL, Rosner BA, Colditz GA. Longitudinal Analysis of Change in Mammographic Density in Each Breast and Its Association With Breast Cancer Risk. JAMA Oncol 2023; 9:808.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ziv E, Tice J, Smith-Bindman R, et al. Mammographic density and estrogen receptor status of breast cancer. Cancer Epidemiol Biomarkers Prev 2004; 13:2090.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Yaghjyan L, Colditz GA, Collins LC, et al. Mammographic breast density and subsequent risk of breast cancer in postmenopausal women according to tumor characteristics. J Natl Cancer Inst 2011; 103:1179.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gierach GL, Ichikawa L, Kerlikowske K, et al. Relationship between mammographic density and breast cancer death in the Breast Cancer Surveillance Consortium. J Natl Cancer Inst 2012; 104:1218.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Boyd NF, Dite GS, Stone J, et al. Heritability of mammographic density, a risk factor for breast cancer. N Engl J Med 2002; 347:886.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Vachon CM, Sellers TA, Carlson EE, et al. Strong evidence of a genetic determinant for mammographic density, a major risk factor for breast cancer. Cancer Res 2007; 67:8412.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Irwin ML, Aiello EJ, McTiernan A, et al. Physical activity, body mass index, and mammographic density in postmenopausal breast cancer survivors. J Clin Oncol 2007; 25:1061.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Boyd NF, Greenberg C, Lockwood G, et al. Effects at two years of a low-fat, high-carbohydrate diet on radiologic features of the breast: results from a randomized trial. Canadian Diet and Breast Cancer Prevention Study Group. J Natl Cancer Inst 1997; 89:488.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           McTiernan A, Martin CF, Peck JD, et al. Estrogen-plus-progestin use and mammographic density in postmenopausal women: Women's Health Initiative randomized trial. J Natl Cancer Inst 2005; 97:1366.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           McTiernan A, Chlebowski RT, Martin C, et al. Conjugated equine estrogen influence on mammographic density in postmenopausal women in a substudy of the women's health initiative randomized trial. J Clin Oncol 2009; 27:6135.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Byrne C, Ursin G, Martin CF, et al. Mammographic Density Change With Estrogen and Progestin Therapy and Breast Cancer Risk. J Natl Cancer Inst 2017; 109.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Slanetz PJ, Grandpre LE, Yeh ED, et al. Effect of tamoxifen on breast tissue density in premenopausal breast cancer. Breast J 2004; 10:27.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cuzick J, Warwick J, Pinney E, et al. Tamoxifen and breast density in women at increased risk of breast cancer. J Natl Cancer Inst 2004; 96:621.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tamimi RM, Byrne C, Colditz GA, Hankinson SE. Endogenous hormone levels, mammographic density, and subsequent risk of breast cancer in postmenopausal women. J Natl Cancer Inst 2007; 99:1178.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Zhang Y, Kiel DP, Kreger BE, et al. Bone mass and the risk of breast cancer among postmenopausal women. N Engl J Med 1997; 336:611.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cauley JA, Lucas FL, Kuller LH, et al. Bone mineral density and risk of breast cancer in older women: the study of osteoporotic fractures. Study of Osteoporotic Fractures Research Group. JAMA 1996; 276:1404.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chen Z, Arendell L, Aickin M, et al. Hip bone density predicts breast cancer risk independently of Gail score: results from the Women's Health Initiative. Cancer 2008; 113:907.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Qu X, Zhang X, Qin A, et al. Bone mineral density and risk of breast cancer in postmenopausal women. Breast Cancer Res Treat 2013; 138:261.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Key TJ, Appleby PN, Reeves GK, et al. Steroid hormone measurements from different types of assays in relation to body mass index and breast cancer risk in postmenopausal women: Reanalysis of eighteen prospective studies. Steroids 2015; 99:49.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Missmer SA, Eliassen AH, Barbieri RL, Hankinson SE. Endogenous estrogen, androgen, and progesterone concentrations and breast cancer risk among postmenopausal women. J Natl Cancer Inst 2004; 96:1856.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Beattie MS, Costantino JP, Cummings SR, et al. Endogenous sex hormones, breast cancer risk, and tamoxifen response: an ancillary study in the NSABP Breast Cancer Prevention Trial (P-1). J Natl Cancer Inst 2006; 98:110.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Farhat GN, Cummings SR, Chlebowski RT, et al. Sex hormone levels and risks of estrogen receptor-negative and estrogen receptor-positive breast cancers. J Natl Cancer Inst 2011; 103:562.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Endogenous Hormones and Breast Cancer Collaborative Group, Key TJ, Appleby PN, et al. Sex hormones and risk of breast cancer in premenopausal women: a collaborative reanalysis of individual participant data from seven prospective studies. Lancet Oncol 2013; 14:1009.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Brettes JP, Mathelin C. [Dual effects of androgens on mammary gland]. Bull Cancer 2008; 95:495.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Dorgan JF, Stanczyk FZ, Kahle LL, Brinton LA. Prospective case-control study of premenopausal serum estradiol and testosterone levels and breast cancer risk. Breast Cancer Res 2010; 12:R98.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Eliassen AH, Missmer SA, Tworoger SS, et al. Endogenous steroid hormone concentrations and risk of breast cancer among premenopausal women. J Natl Cancer Inst 2006; 98:1406.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kaaks R, Berrino F, Key T, et al. Serum sex steroids in premenopausal women and breast cancer risk within the European Prospective Investigation into Cancer and Nutrition (EPIC). J Natl Cancer Inst 2005; 97:755.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tworoger SS, Missmer SA, Eliassen AH, et al. The association of plasma DHEA and DHEA sulfate with breast cancer risk in predominantly premenopausal women. Cancer Epidemiol Biomarkers Prev 2006; 15:967.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pan K, Nelson RA, Wactawski-Wende J, et al. Insulin Resistance and Cancer-Specific and All-Cause Mortality in Postmenopausal Women: The Women's Health Initiative. J Natl Cancer Inst 2020; 112:170.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pan K, Chlebowski RT, Mortimer JE, et al. Insulin resistance and breast cancer incidence and mortality in postmenopausal women in the Women's Health Initiative. Cancer 2020; 126:3638.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wolf I, Sadetzki S, Catane R, et al. Diabetes mellitus and breast cancer. Lancet Oncol 2005; 6:103.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Endogenous Hormones and Breast Cancer Collaborative Group, Key TJ, Appleby PN, et al. Insulin-like growth factor 1 (IGF1), IGF binding protein 3 (IGFBP3), and breast cancer risk: pooled individual data analysis of 17 prospective studies. Lancet Oncol 2010; 11:530.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Collaborative Group on Hormonal Factors in Breast Cancer. Menarche, menopause, and breast cancer risk: individual participant meta-analysis, including 118 964 women with breast cancer from 117 epidemiological studies. Lancet Oncol 2012; 13:1141.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Colditz GA, Rosner B. Cumulative risk of breast cancer to age 70 years according to risk factor status: data from the Nurses' Health Study. Am J Epidemiol 2000; 152:950.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rosner B, Colditz GA, Willett WC. Reproductive risk factors in a prospective study of breast cancer: the Nurses' Health Study. Am J Epidemiol 1994; 139:819.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kelsey JL, Gammon MD, John EM. Reproductive factors and breast cancer. Epidemiol Rev 1993; 15:36.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Colditz GA, Frazier AL. Models of breast cancer show that risk is set by events of early life: prevention efforts must shift focus. Cancer Epidemiol Biomarkers Prev 1995; 4:567.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Nichols HB, Berrington de González A, Lacey JV Jr, et al. Declining incidence of contralateral breast cancer in the United States from 1975 to 2006. J Clin Oncol 2011; 29:1564.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pan H, Gray R, Braybrooke J, et al. 20-Year Risks of Breast-Cancer Recurrence after Stopping Endocrine Therapy at 5 Years. N Engl J Med 2017; 377:1836.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Reiner AS, Sisti J, John EM, et al. Breast Cancer Family History and Contralateral Breast Cancer Risk in Young Women: An Update From the Women's Environmental Cancer and Radiation Epidemiology Study. J Clin Oncol 2018; 36:1513.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Collaborative Group on Hormonal Factors in Breast Cancer. Familial breast cancer: collaborative reanalysis of individual data from 52 epidemiological studies including 58,209 women with breast cancer and 101,986 women without the disease. Lancet 2001; 358:1389.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Braithwaite D, Miglioretti DL, Zhu W, et al. Family History and Breast Cancer Risk Among Older Women in the Breast Cancer Surveillance Consortium Cohort. JAMA Intern Med 2018; 178:494.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gram IT, Park SY, Kolonel LN, et al. Smoking and Risk of Breast Cancer in a Racially/Ethnically Diverse Population of Mainly Women Who Do Not Drink Alcohol: The MEC Study. Am J Epidemiol 2015; 182:917.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gaudet MM, Carter BD, Brinton LA, et al. Pooled analysis of active cigarette smoking and invasive breast cancer risk in 14 cohort studies. Int J Epidemiol 2017; 46:881.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Macacu A, Autier P, Boniol M, Boyle P. Active and passive smoking and risk of breast cancer: a meta-analysis. Breast Cancer Res Treat 2015; 154:213.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gaudet MM, Gapstur SM, Sun J, et al. Active smoking and breast cancer risk: original cohort data and meta-analysis. J Natl Cancer Inst 2013; 105:515.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Johnson KC, Miller AB, Collishaw NE, et al. Active smoking and secondhand smoke increase breast cancer risk: the report of the Canadian Expert Panel on Tobacco Smoke and Breast Cancer Risk (2009). Tob Control 2011; 20:e2.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Park HA, Neumeyer S, Michailidou K, et al. Mendelian randomisation study of smoking exposure in relation to breast cancer risk. Br J Cancer 2021; 125:1135.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Anderson LN, Cotterchio M, Mirea L, et al. Passive cigarette smoke exposure during various periods of life, genetic variants, and breast cancer risk among never smokers. Am J Epidemiol 2012; 175:289.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Dossus L, Boutron-Ruault MC, Kaaks R, et al. Active and passive cigarette smoking and breast cancer risk: results from the EPIC cohort. Int J Cancer 2014; 134:1871.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Henderson TO, Amsterdam A, Bhatia S, et al. Systematic review: surveillance for breast cancer in women treated with chest radiation for childhood, adolescent, or young adult cancer. Ann Intern Med 2010; 152:444.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pukkala E, Kesminiene A, Poliakov S, et al. Breast cancer in Belarus and Ukraine after the Chernobyl accident. Int J Cancer 2006; 119:651.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ostroumova E, Preston DL, Ron E, et al. Breast cancer incidence following low-dose rate environmental exposure: Techa River Cohort, 1956-2004. Br J Cancer 2008; 99:1940.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           John EM, Kelsey JL. Radiation and other environmental exposures and breast cancer. Epidemiol Rev 1993; 15:157.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Collaborative Group on Hormonal Factors in Breast Cancer. Breast cancer and breastfeeding: collaborative reanalysis of individual data from 47 epidemiological studies in 30 countries, including 50302 women with breast cancer and 96973 women without the disease. Lancet 2002; 360:187.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Islami F, Liu Y, Jemal A, et al. Breastfeeding and breast cancer risk by receptor status--a systematic review and meta-analysis. Ann Oncol 2015; 26:2398.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pizot C, Boniol M, Mullie P, et al. Physical activity, hormone replacement therapy and breast cancer risk: A meta-analysis of prospective studies. Eur J Cancer 2016; 52:138.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kehm RD, Genkinger JM, MacInnis RJ, et al. Recreational Physical Activity Is Associated with Reduced Breast Cancer Risk in Adult Women at High Risk for Breast Cancer: A Cohort Study of Women Selected for Familial and Genetic Risk. Cancer Res 2020; 80:116.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           McTiernan A, Kooperberg C, White E, et al. Recreational physical activity and the risk of breast cancer in postmenopausal women: the Women's Health Initiative Cohort Study. JAMA 2003; 290:1331.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hardefeldt PJ, Penninkilampi R, Edirimanne S, Eslick GD. Physical Activity and Weight Loss Reduce the Risk of Breast Cancer: A Meta-analysis of 139 Prospective and Retrospective Studies. Clin Breast Cancer 2018; 18:e601.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Brinton LA, Bernstein L, Colditz GA. Summary of the workshop: Workshop on Physical Activity and Breast Cancer, November 13-14, 1997. Cancer 1998; 83:595.
          </a>
         </li>
         <li class="breakAll">
          Willett WC, Rockhill B, Hankinson SE, et al. Nongenetic factors in the causation of breast cancer. In: Diseases of the Breast, 3rd ed, Harris JR, Lippman ME, Morrow M, Osborne CK (Eds), Lippincott, Williams and Wilkins, Philadelphia 2004. p.253.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Thune I, Brenn T, Lund E, Gaard M. Physical activity and the risk of breast cancer. N Engl J Med 1997; 336:1269.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Maruti SS, Willett WC, Feskanich D, et al. A prospective study of age-specific physical activity and premenopausal breast cancer. J Natl Cancer Inst 2008; 100:728.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ligibel JA, Campbell N, Partridge A, et al. Impact of a mixed strength and endurance exercise intervention on insulin levels in breast cancer survivors. J Clin Oncol 2008; 26:907.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Fairey AS, Courneya KS, Field CJ, et al. Effects of exercise training on fasting insulin, insulin resistance, insulin-like growth factors, and insulin-like growth factor binding proteins in postmenopausal breast cancer survivors: a randomized controlled trial. Cancer Epidemiol Biomarkers Prev 2003; 12:721.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Irwin ML, Varma K, Alvarez-Reeves M, et al. Randomized controlled trial of aerobic exercise on insulin and insulin-like growth factors in breast cancer survivors: the Yale Exercise and Survivorship study. Cancer Epidemiol Biomarkers Prev 2009; 18:306.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Michels KB, Terry KL, Eliassen AH, et al. Adult weight change and incidence of premenopausal breast cancer. Int J Cancer 2012; 130:902.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chlebowski RT, Luo J, Anderson GL, et al. Weight loss and breast cancer incidence in postmenopausal women. Cancer 2019; 125:205.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Teras LR, Patel AV, Wang M, et al. Sustained Weight Loss and Risk of Breast Cancer in Women 50 Years and Older: A Pooled Analysis of Prospective Data. J Natl Cancer Inst 2020; 112:929.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Arthur RS, Wang T, Xue X, et al. Genetic Factors, Adherence to Healthy Lifestyle Behavior, and Risk of Invasive Breast Cancer Among Women in the UK Biobank. J Natl Cancer Inst 2020; 112:893.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Harvie M, Howell A, Vierkant RA, et al. Association of gain and loss of weight before and after menopause with risk of postmenopausal breast cancer in the Iowa women's health study. Cancer Epidemiol Biomarkers Prev 2005; 14:656.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Parker ED, Folsom AR. Intentional weight loss and incidence of obesity-related cancers: the Iowa Women's Health Study. Int J Obes Relat Metab Disord 2003; 27:1447.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kawai M, Minami Y, Kuriyama S, et al. Adiposity, adult weight change and breast cancer risk in postmenopausal Japanese women: the Miyagi Cohort Study. Br J Cancer 2010; 103:1443.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Van Horn L, Aragaki AK, Howard BV, et al. Eating Pattern Response to a Low-Fat Diet Intervention and Cardiovascular Outcomes in Normotensive Women: The Women's Health Initiative. Curr Dev Nutr 2020; 4:nzaa021.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Appel LJ, Moore TJ, Obarzanek E, et al. A clinical trial of the effects of dietary patterns on blood pressure. DASH Collaborative Research Group. N Engl J Med 1997; 336:1117.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chlebowski RT, Aragaki AK, Anderson GL, et al. Association of Low-Fat Dietary Pattern With Breast Cancer Overall Survival: A Secondary Analysis of the Women's Health Initiative Randomized Clinical Trial. JAMA Oncol 2018; 4:e181212.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chlebowski RT, Aragaki AK, Anderson GL, et al. Dietary Modification and Breast Cancer Mortality: Long-Term Follow-Up of the Women's Health Initiative Randomized Trial. J Clin Oncol 2020; 38:1419.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Prentice RL, Caan B, Chlebowski RT, et al. Low-fat dietary pattern and risk of invasive breast cancer: the Women's Health Initiative Randomized Controlled Dietary Modification Trial. JAMA 2006; 295:629.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Toledo E, Salas-Salvadó J, Donat-Vargas C, et al. Mediterranean Diet and Invasive Breast Cancer Risk Among Women at High Cardiovascular Risk in the PREDIMED Trial: A Randomized Clinical Trial. JAMA Intern Med 2015; 175:1752.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Du M, Liu SH, Mitchell C, Fung TT. Associations between Diet Quality Scores and Risk of Postmenopausal Estrogen Receptor-Negative Breast Cancer: A Systematic Review. J Nutr 2018; 148:100.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           van den Brandt PA, Schulpen M. Mediterranean diet adherence and risk of postmenopausal breast cancer: results of a cohort study and meta-analysis. Int J Cancer 2017; 140:2220.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Fung TT, Hu FB, McCullough ML, et al. Diet quality is associated with the risk of estrogen receptor-negative breast cancer in postmenopausal women. J Nutr 2006; 136:466.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Catsburg C, Kim RS, Kirsh VA, et al. Dietary patterns and breast cancer risk: a study in 2 cohorts. Am J Clin Nutr 2015; 101:817.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Jung S, Spiegelman D, Baglietto L, et al. Fruit and vegetable intake and risk of breast cancer by hormone receptor status. J Natl Cancer Inst 2013; 105:219.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Farvid MS, Chen WY, Michels KB, et al. Fruit and vegetable consumption in adolescence and early adulthood and risk of breast cancer: population based cohort study. BMJ 2016; 353:i2343.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Brennan SF, Cantwell MM, Cardwell CR, et al. Dietary patterns and breast cancer risk: a systematic review and meta-analysis. Am J Clin Nutr 2010; 91:1294.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Eliassen AH, Hendrickson SJ, Brinton LA, et al. Circulating carotenoids and risk of breast cancer: pooled analysis of eight prospective studies. J Natl Cancer Inst 2012; 104:1905.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Alexander DD, Morimoto LM, Mink PJ, Lowe KA. Summary and meta-analysis of prospective studies of animal fat intake and breast cancer. Nutr Res Rev 2010; 23:169.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Thiébaut AC, Kipnis V, Chang SC, et al. Dietary fat and postmenopausal invasive breast cancer in the National Institutes of Health-AARP Diet and Health Study cohort. J Natl Cancer Inst 2007; 99:451.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Brennan SF, Woodside JV, Lunny PM, et al. Dietary fat and breast cancer mortality: A systematic review and meta-analysis. Crit Rev Food Sci Nutr 2017; 57:1999.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Day N, McKeown N, Wong M, et al. Epidemiological assessment of diet: a comparison of a 7-day diary with a food frequency questionnaire using urinary markers of nitrogen, potassium and sodium. Int J Epidemiol 2001; 30:309.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bingham SA, Luben R, Welch A, et al. Are imprecise methods obscuring a relation between fat and breast cancer? Lancet 2003; 362:212.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chen M, Rao Y, Zheng Y, et al. Association between soy isoflavone intake and breast cancer risk for pre- and post-menopausal women: a meta-analysis of epidemiological studies. PLoS One 2014; 9:e89288.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Farvid MS, Stern MC, Norat T, et al. Consumption of red and processed meat and breast cancer incidence: A systematic review and meta-analysis of prospective studies. Int J Cancer 2018; 143:2787.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Anderson JJ, Darwis NDM, Mackay DF, et al. Red and processed meat consumption and breast cancer: UK Biobank cohort study and meta-analysis. Eur J Cancer 2018; 90:73.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Boyd NF, Stone J, Vogt KN, et al. Dietary fat and breast cancer risk revisited: a meta-analysis of the published literature. Br J Cancer 2003; 89:1672.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cho E, Chen WY, Hunter DJ, et al. Red meat intake and risk of breast cancer among premenopausal women. Arch Intern Med 2006; 166:2253.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Taylor EF, Burley VJ, Greenwood DC, Cade JE. Meat consumption and risk of breast cancer in the UK Women's Cohort Study. Br J Cancer 2007; 96:1139.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chen S, Chen Y, Ma S, et al. Dietary fibre intake and risk of breast cancer: A systematic review and meta-analysis of epidemiological studies. Oncotarget 2016; 7:80980.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Whittemore AS. Breast cancer in Marin County. Breast Cancer Res 2003; 5:232.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Vieira V, Webster T, Weinberg J, et al. Spatial analysis of lung, colorectal, and breast cancer on Cape Cod: an application of generalized additive models to case-control data. Environ Health 2005; 4:11.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kulldorff M, Feuer EJ, Miller BA, Freedman LS. Breast cancer clusters in the northeast United States: a geographic analysis. Am J Epidemiol 1997; 146:161.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sturgeon SR, Schairer C, Gail M, et al. Geographic variation in mortality from breast cancer among white women in the United States. J Natl Cancer Inst 1995; 87:1846.
          </a>
         </li>
         <li class="breakAll">
          Willett WC, Rockhill B, Hankinson SE, et al. Nongenetic factors in the causation of breast cancer. In: Diseases of the Breast, 3rd ed, Harris JR, Lippman ME, Morrow M, Osborne CK (Eds), Lippincott, Williams and Wilkins, Philadeliphia 2004. p.223.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Dutkowsky JP, Shearer D, Schepps B, et al. Radiation exposure to patients receiving routine scoliosis radiography measured at depth in an anthropomorphic phantom. J Pediatr Orthop 1990; 10:532.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hoffman DA, Lonstein JE, Morin MM, et al. Breast cancer in women with scoliosis exposed to multiple diagnostic x rays. J Natl Cancer Inst 1989; 81:1307.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Miglioretti DL, Lange J, van den Broek JJ, et al. Radiation-Induced Breast Cancer Incidence and Mortality From Digital Mammography Screening: A Modeling Study. Ann Intern Med 2016; 164:205.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Narod SA, Lubinski J, Ghadirian P, et al. Screening mammography and risk of breast cancer in BRCA1 and BRCA2 mutation carriers: a case-control study. Lancet Oncol 2006; 7:402.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pijpe A, Andrieu N, Easton DF, et al. Exposure to diagnostic radiation and risk of breast cancer among carriers of BRCA1/2 mutations: retrospective cohort study (GENE-RAD-RISK). BMJ 2012; 345:e5660.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Andrieu N, Easton DF, Chang-Claude J, et al. Effect of chest X-rays on the risk of breast cancer among BRCA1/2 mutation carriers in the international BRCA1/2 carrier cohort study: a report from the EMBRACE, GENEPSO, GEO-HEBON, and IBCCS Collaborators' Group. J Clin Oncol 2006; 24:3361.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bauer SR, Hankinson SE, Bertone-Johnson ER, Ding EL. Plasma vitamin D levels, menopause, and risk of breast cancer: dose-response meta-analysis of prospective studies. Medicine (Baltimore) 2013; 92:123.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Zhou L, Chen B, Sheng L, Turner A. The effect of vitamin D supplementation on the risk of breast cancer: a trial sequential meta-analysis. Breast Cancer Res Treat 2020; 182:1.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chlebowski RT, Johnson KC, Kooperberg C, et al. Calcium plus vitamin D supplementation and the risk of breast cancer. J Natl Cancer Inst 2008; 100:1581.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cauley JA, Chlebowski RT, Wactawski-Wende J, et al. Calcium plus vitamin D supplementation and health outcomes five years after active intervention ended: the Women's Health Initiative. J Womens Health (Larchmt) 2013; 22:915.
          </a>
         </li>
         <li class="breakAll">
          The VITamin D and OmegA-3 TriaL (VITAL) study. http://www.vitalstudy.org/ (Accessed on July 18, 2019).
         </li>
         <li>
          <a class="nounderline abstract_t">
           Manson JE, Bassuk SS, Buring JE, VITAL Research Group. Principal results of the VITamin D and OmegA-3 TriaL (VITAL) and updated meta-analyses of relevant vitamin D trials. J Steroid Biochem Mol Biol 2020; 198:105522.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           de Pedro M, Baeza S, Escudero MT, et al. Effect of COX-2 inhibitors and other non-steroidal inflammatory drugs on breast cancer risk: a meta-analysis. Breast Cancer Res Treat 2015; 149:525.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Zhang X, Smith-Warner SA, Collins LC, et al. Use of aspirin, other nonsteroidal anti-inflammatory drugs, and acetaminophen and postmenopausal breast cancer incidence. J Clin Oncol 2012; 30:3468.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cook NR, Lee IM, Gaziano JM, et al. Low-dose aspirin in the primary prevention of cancer: the Women's Health Study: a randomized controlled trial. JAMA 2005; 294:47.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chlebowski RT, Chen Z, Cauley JA, et al. Oral bisphosphonate use and breast cancer incidence in postmenopausal women. J Clin Oncol 2010; 28:3582.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rennert G, Pinchev M, Rennert HS. Use of bisphosphonates and risk of postmenopausal breast cancer. J Clin Oncol 2010; 28:3577.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Monsees GM, Malone KE, Tang MT, et al. Bisphosphonate use after estrogen receptor-positive breast cancer and risk of contralateral breast cancer. J Natl Cancer Inst 2011; 103:1752.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Newcomb PA, Trentham-Dietz A, Hampton JM. Bisphosphonates for osteoporosis treatment are associated with reduced breast cancer risk. Br J Cancer 2010; 102:799.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Fournier A, Mesrine S, Gelot A, et al. Use of Bisphosphonates and Risk of Breast Cancer in a French Cohort of Postmenopausal Women. J Clin Oncol 2017; 35:3230.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Blount BC, Silva MJ, Caudill SP, et al. Levels of seven urinary phthalate metabolites in a human reference population. Environ Health Perspect 2000; 108:979.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hauser R, Duty S, Godfrey-Bailey L, Calafat AM. Medications as a source of human exposure to phthalates. Environ Health Perspect 2004; 112:751.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Buck Louis GM, Sundaram R, Sweeney AM, et al. Urinary bisphenol A, phthalates, and couple fecundity: the Longitudinal Investigation of Fertility and the Environment (LIFE) Study. Fertil Steril 2014; 101:1359.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Reeves KW, Díaz Santana M, Manson JE, et al. Urinary Phthalate Biomarker Concentrations and Postmenopausal Breast Cancer Risk. J Natl Cancer Inst 2019; 111:1059.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ahern TP, Broe A, Lash TL, et al. Phthalate Exposure and Breast Cancer Incidence: A Danish Nationwide Cohort Study. J Clin Oncol 2019; 37:1800.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rossing MA, Daling JR, Weiss NS, et al. Risk of breast cancer in a cohort of infertile women. Gynecol Oncol 1996; 60:3.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gammon MD, Thompson WD. Infertility and breast cancer: a population-based case-control study. Am J Epidemiol 1990; 132:708.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Modan B, Ron E, Lerner-Geva L, et al. Cancer incidence in a cohort of infertile women. Am J Epidemiol 1998; 147:1038.
          </a>
         </li>
         <li class="breakAll">
          Shiftwork. IARC Monographs Volume 98. http://monographs.iarc.fr/ENG/Monographs/vol98/mono98-8.pdf (Accessed on February 15, 2021).
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hansen J, Stevens RG. Case-control study of shift-work and breast cancer risk in Danish nurses: impact of shift systems. Eur J Cancer 2012; 48:1722.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Travis RC, Balkwill A, Fensom GK, et al. Night Shift Work and Breast Cancer Incidence: Three Prospective Studies and Meta-analysis of Published Studies. J Natl Cancer Inst 2016; 108.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wang F, Yeung KL, Chan WC, et al. A meta-analysis on dose-response relationship between night shift work and the risk of breast cancer. Ann Oncol 2013; 24:2724.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Schernhammer ES, Hankinson SE. Urinary melatonin levels and breast cancer risk. J Natl Cancer Inst 2005; 97:1084.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Schernhammer ES, Berrino F, Krogh V, et al. Urinary 6-sulfatoxymelatonin levels and risk of breast cancer in postmenopausal women. J Natl Cancer Inst 2008; 100:898.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Beral V, Bull D, Doll R, et al. Breast cancer and abortion: collaborative reanalysis of data from 53 epidemiological studies, including 83?000 women with breast cancer from 16 countries. Lancet 2004; 363:1007.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Melbye M, Wohlfahrt J, Olsen JH, et al. Induced abortion and the risk of breast cancer. N Engl J Med 1997; 336:81.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Reeves GK, Kan SW, Key T, et al. Breast cancer risk in relation to abortion: Results from the EPIC study. Int J Cancer 2006; 119:1741.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Paoletti X, Clavel-Chapelon F. Induced and spontaneous abortion and breast cancer risk: results from the E3N cohort study. Int J Cancer 2003; 106:270.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Michels KB, Xue F, Colditz GA, Willett WC. Induced and spontaneous abortion and incidence of breast cancer among young women: a prospective cohort study. Arch Intern Med 2007; 167:814.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Erlandsson G, Montgomery SM, Cnattingius S, Ekbom A. Abortions and breast cancer: record-based case-control study. Int J Cancer 2003; 103:676.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Calle EE, Frumkin H, Henley SJ, et al. Organochlorines and breast cancer risk. CA Cancer J Clin 2002; 52:301.
          </a>
         </li>
         <li class="breakAll">
          Willett WC, Rockhill B, Hankinson SE, et al. factors in the causation of breast cancer. In: Diseases of the Breast, 3rd ed, Harris JR, Lippman ME, Morrow M, Osborne CK (Eds), Lippincott, Williams and Wilkins, Philadelphia 2004. p.255.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lin J, Cook NR, Albert C, et al. Vitamins C and E and beta carotene supplementation and cancer risk: a randomized controlled trial. J Natl Cancer Inst 2009; 101:14.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Nagel G, Linseisen J, van Gils CH, et al. Dietary beta-carotene, vitamin C and E intake and breast cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC). Breast Cancer Res Treat 2010; 119:753.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gaudet MM, Patel AV, Sun J, et al. Tubal sterilization and breast cancer incidence: results from the cancer prevention study II nutrition cohort and meta-analysis. Am J Epidemiol 2013; 177:492.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gierach GL, Freedman ND, Andaya A, et al. Coffee intake and breast cancer risk in the NIH-AARP diet and health study cohort. Int J Cancer 2012; 131:452.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hashibe M, Galeone C, Buys SS, et al. Coffee, tea, caffeine intake, and the risk of cancer in the PLCO cohort. Br J Cancer 2015; 113:809.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lipworth L, Tarone RE, Friis S, et al. Cancer among Scandinavian women with cosmetic breast implants: a pooled long-term follow-up study. Int J Cancer 2009; 124:490.
          </a>
         </li>
        </ol>
       </div>
       <div id="topicVersionRevision">
        Topic 792 Version 82.0
       </div>
      </div>
      <div class="row">
       <div class="col-12">
        <h4 style="text-align: center;padding: 20px;color: cadetblue;">
         References
        </h4>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33538338" id="rid0" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          1 : Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33433946" id="rid1" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          2 : Cancer Statistics, 2021.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15770008" id="rid2" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          3 : Ethnicity and breast cancer: factors influencing differences in incidence and outcome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27736827" id="rid3" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          4 : Patterns and Trends in Age-Specific Black-White Differences in Breast Cancer Incidence and Mortality - United States, 1999-2014.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16757721" id="rid4" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          5 : Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27356115" id="rid5" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          6 : Obesity: definition, comorbidities, causes, and burden.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15252848" id="rid6" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          7 : Body size and breast cancer risk: findings from the European Prospective Investigation into Cancer And Nutrition (EPIC).
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16835425" id="rid7" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          8 : Adult weight change and risk of postmenopausal breast cancer.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12420953" id="rid8" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          9 : Obesity, body size, and risk of postmenopausal breast cancer: the Women's Health Initiative (United States).
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27557308" id="rid9" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          10 : Body Fatness and Cancer--Viewpoint of the IARC Working Group.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25757865" id="rid10" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          11 : Adult weight gain and adiposity-related cancers: a dose-response meta-analysis of prospective observational studies.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12928347" id="rid11" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          12 : Body mass index, serum sex hormones, and breast cancer risk in postmenopausal women.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26182172" id="rid12" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          13 : Overweight, Obesity, and Postmenopausal Invasive Breast Cancer Risk: A Secondary Analysis of the Women's Health Initiative Randomized Clinical Trials.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19116382" id="rid13" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          14 : Insulin, insulin-like growth factor-I, and risk of breast cancer in postmenopausal women.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32721007" id="rid14" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          15 : Association of Menopausal Hormone Therapy With Breast Cancer Incidence and Mortality During Long-term Follow-up of the Women's Health Initiative Randomized Clinical Trials.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22547473" id="rid15" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          16 : Risk factors for breast cancer for women aged 40 to 49 years: a systematic review and meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29931120" id="rid16" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          17 : Association of Body Mass Index and Age With Subsequent Breast Cancer Risk in Premenopausal Women.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15483280" id="rid17" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          18 : Growth patterns and the risk of breast cancer in women.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21782509" id="rid18" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          19 : Height and cancer incidence in the Million Women Study: prospective cohort, and meta-analysis of prospective studies of height and total cancer risk.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10997541" id="rid19" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          20 : Pooled analysis of prospective cohort studies on height, weight, and breast cancer risk.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23090881" id="rid20" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          21 : Height, age at menarche and risk of hormone receptor-positive and -negative breast cancer: a cohort study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16775176" id="rid21" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          22 : Breast density and parenchymal patterns as markers of breast cancer risk: a meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17229950" id="rid22" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          23 : Mammographic density and the risk and detection of breast cancer.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16198986" id="rid23" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          24 : Mammographic breast density as an intermediate phenotype for breast cancer.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21245860" id="rid24" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          25 : Mammographic density and its interaction with other breast cancer risk factors in an Asian population.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/34436608" id="rid25" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          26 : Association of Breast Density With Breast Cancer Risk Among Women Aged 65 Years or Older by Age Group and Body Mass Index.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17341730" id="rid26" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          27 : Longitudinal measurement of clinical mammographic breast density to improve estimation of breast cancer risk.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/37103922" id="rid27" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          28 : Longitudinal Analysis of Change in Mammographic Density in Each Breast and Its Association With Breast Cancer Risk.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15598766" id="rid28" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          29 : Mammographic density and estrogen receptor status of breast cancer.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21795664" id="rid29" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          30 : Mammographic breast density and subsequent risk of breast cancer in postmenopausal women according to tumor characteristics.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22911616" id="rid30" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          31 : Relationship between mammographic density and breast cancer death in the Breast Cancer Surveillance Consortium.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12239257" id="rid31" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          32 : Heritability of mammographic density, a risk factor for breast cancer.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17804758" id="rid32" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          33 : Strong evidence of a genetic determinant for mammographic density, a major risk factor for breast cancer.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17261853" id="rid33" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          34 : Physical activity, body mass index, and mammographic density in postmenopausal breast cancer survivors.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9086005" id="rid34" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          35 : Effects at two years of a low-fat, high-carbohydrate diet on radiologic features of the breast: results from a randomized trial. Canadian Diet and Breast Cancer Prevention Study Group.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16174858" id="rid35" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          36 : Estrogen-plus-progestin use and mammographic density in postmenopausal women: Women's Health Initiative randomized trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19901118" id="rid36" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          37 : Conjugated equine estrogen influence on mammographic density in postmenopausal women in a substudy of the women's health initiative randomized trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28376149" id="rid37" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          38 : Mammographic Density Change With Estrogen and Progestin Therapy and Breast Cancer Risk.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/14717756" id="rid38" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          39 : Effect of tamoxifen on breast tissue density in premenopausal breast cancer.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15100340" id="rid39" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          40 : Tamoxifen and breast density in women at increased risk of breast cancer.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17652278" id="rid40" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          41 : Endogenous hormone levels, mammographic density, and subsequent risk of breast cancer in postmenopausal women.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9032046" id="rid41" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          42 : Bone mass and the risk of breast cancer among postmenopausal women.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8892715" id="rid42" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          43 : Bone mineral density and risk of breast cancer in older women: the study of osteoporotic fractures. Study of Osteoporotic Fractures Research Group.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18666209" id="rid43" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          44 : Hip bone density predicts breast cancer risk independently of Gail score: results from the Women's Health Initiative.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23381744" id="rid44" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          45 : Bone mineral density and risk of breast cancer in postmenopausal women.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25304359" id="rid45" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          46 : Steroid hormone measurements from different types of assays in relation to body mass index and breast cancer risk in postmenopausal women: Reanalysis of eighteen prospective studies.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15601642" id="rid46" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          47 : Endogenous estrogen, androgen, and progesterone concentrations and breast cancer risk among postmenopausal women.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16418513" id="rid47" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          48 : Endogenous sex hormones, breast cancer risk, and tamoxifen response: an ancillary study in the NSABP Breast Cancer Prevention Trial (P-1).
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21330633" id="rid48" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          49 : Sex hormone levels and risks of estrogen receptor-negative and estrogen receptor-positive breast cancers.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23890780" id="rid49" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          50 : Sex hormones and risk of breast cancer in premenopausal women: a collaborative reanalysis of individual participant data from seven prospective studies.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18541513" id="rid50" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          51 : [Dual effects of androgens on mammary gland].
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21087481" id="rid51" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          52 : Prospective case-control study of premenopausal serum estradiol and testosterone levels and breast cancer risk.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17018787" id="rid52" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          53 : Endogenous steroid hormone concentrations and risk of breast cancer among premenopausal women.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15900045" id="rid53" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          54 : Serum sex steroids in premenopausal women and breast cancer risk within the European Prospective Investigation into Cancer and Nutrition (EPIC).
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16702378" id="rid54" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          55 : The association of plasma DHEA and DHEA sulfate with breast cancer risk in predominantly premenopausal women.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31184362" id="rid55" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          56 : Insulin Resistance and Cancer-Specific and All-Cause Mortality in Postmenopausal Women: The Women's Health Initiative.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32530506" id="rid56" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          57 : Insulin resistance and breast cancer incidence and mortality in postmenopausal women in the Women's Health Initiative.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15683819" id="rid57" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          58 : Diabetes mellitus and breast cancer.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20472501" id="rid58" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          59 : Insulin-like growth factor 1 (IGF1), IGF binding protein 3 (IGFBP3), and breast cancer risk: pooled individual data analysis of 17 prospective studies.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23084519" id="rid59" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          60 : Menarche, menopause, and breast cancer risk: individual participant meta-analysis, including 118 964 women with breast cancer from 117 epidemiological studies.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11092437" id="rid60" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          61 : Cumulative risk of breast cancer to age 70 years according to risk factor status: data from the Nurses' Health Study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8178795" id="rid61" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          62 : Reproductive risk factors in a prospective study of breast cancer: the Nurses' Health Study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8405211" id="rid62" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          63 : Reproductive factors and breast cancer.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7549816" id="rid63" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          64 : Models of breast cancer show that risk is set by events of early life: prevention efforts must shift focus.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21402610" id="rid64" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          65 : Declining incidence of contralateral breast cancer in the United States from 1975 to 2006.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29117498" id="rid65" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          66 : 20-Year Risks of Breast-Cancer Recurrence after Stopping Endocrine Therapy at 5 Years.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29620998" id="rid66" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          67 : Breast Cancer Family History and Contralateral Breast Cancer Risk in Young Women: An Update From the Women's Environmental Cancer and Radiation Epidemiology Study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11705483" id="rid67" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          68 : Familial breast cancer: collaborative reanalysis of individual data from 52 epidemiological studies including 58,209 women with breast cancer and 101,986 women without the disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29435563" id="rid68" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          69 : Family History and Breast Cancer Risk Among Older Women in the Breast Cancer Surveillance Consortium Cohort.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26493265" id="rid69" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          70 : Smoking and Risk of Breast Cancer in a Racially/Ethnically Diverse Population of Mainly Women Who Do Not Drink Alcohol: The MEC Study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28031315" id="rid70" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          71 : Pooled analysis of active cigarette smoking and invasive breast cancer risk in 14 cohort studies.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26546245" id="rid71" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          72 : Active and passive smoking and risk of breast cancer: a meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23449445" id="rid72" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          73 : Active smoking and breast cancer risk: original cohort data and meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21148114" id="rid73" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          74 : Active smoking and secondhand smoke increase breast cancer risk: the report of the Canadian Expert Panel on Tobacco Smoke and Breast Cancer Risk (2009).
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/34341517" id="rid74" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          75 : Mendelian randomisation study of smoking exposure in relation to breast cancer risk.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22247046" id="rid75" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          76 : Passive cigarette smoke exposure during various periods of life, genetic variants, and breast cancer risk among never smokers.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24590452" id="rid76" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          77 : Active and passive cigarette smoking and breast cancer risk: results from the EPIC cohort.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20368650" id="rid77" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          78 : Systematic review: surveillance for breast cancer in women treated with chest radiation for childhood, adolescent, or young adult cancer.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16506213" id="rid78" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          79 : Breast cancer in Belarus and Ukraine after the Chernobyl accident.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19002173" id="rid79" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          80 : Breast cancer incidence following low-dose rate environmental exposure: Techa River Cohort, 1956-2004.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8405198" id="rid80" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          81 : Radiation and other environmental exposures and breast cancer.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12133652" id="rid81" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          82 : Breast cancer and breastfeeding: collaborative reanalysis of individual data from 47 epidemiological studies in 30 countries, including 50302 women with breast cancer and 96973 women without the disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26504151" id="rid82" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          83 : Breastfeeding and breast cancer risk by receptor status--a systematic review and meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26687833" id="rid83" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          84 : Physical activity, hormone replacement therapy and breast cancer risk: A meta-analysis of prospective studies.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31578201" id="rid84" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          85 : Recreational Physical Activity Is Associated with Reduced Breast Cancer Risk in Adult Women at High Risk for Breast Cancer: A Cohort Study of Women Selected for Familial and Genetic Risk.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12966124" id="rid85" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          86 : Recreational physical activity and the risk of breast cancer in postmenopausal women: the Women's Health Initiative Cohort Study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29223719" id="rid86" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          87 : Physical Activity and Weight Loss Reduce the Risk of Breast Cancer: A Meta-analysis of 139 Prospective and Retrospective Studies.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9690522" id="rid87" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          88 : Summary of the workshop: Workshop on Physical Activity and Breast Cancer, November 13-14, 1997.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9690522" id="rid88" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          89 : Summary of the workshop: Workshop on Physical Activity and Breast Cancer, November 13-14, 1997.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9113929" id="rid89" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          90 : Physical activity and the risk of breast cancer.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18477801" id="rid90" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          91 : A prospective study of age-specific physical activity and premenopausal breast cancer.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18281663" id="rid91" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          92 : Impact of a mixed strength and endurance exercise intervention on insulin levels in breast cancer survivors.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12917202" id="rid92" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          93 : Effects of exercise training on fasting insulin, insulin resistance, insulin-like growth factors, and insulin-like growth factor binding proteins in postmenopausal breast cancer survivors: a randomized controlled trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19124513" id="rid93" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          94 : Randomized controlled trial of aerobic exercise on insulin and insulin-like growth factors in breast cancer survivors: the Yale Exercise and Survivorship study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21413008" id="rid94" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          95 : Adult weight change and incidence of premenopausal breast cancer.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30294816" id="rid95" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          96 : Weight loss and breast cancer incidence in postmenopausal women.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31845728" id="rid96" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          97 : Sustained Weight Loss and Risk of Breast Cancer in Women 50 Years and Older: A Pooled Analysis of Prospective Data.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31899501" id="rid97" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          98 : Genetic Factors, Adherence to Healthy Lifestyle Behavior, and Risk of Invasive Breast Cancer Among Women in the UK Biobank.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15767346" id="rid98" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          99 : Association of gain and loss of weight before and after menopause with risk of postmenopausal breast cancer in the Iowa women's health study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/14634673" id="rid99" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          100 : Intentional weight loss and incidence of obesity-related cancers: the Iowa Women's Health Study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20842123" id="rid100" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          101 : Adiposity, adult weight change and breast cancer risk in postmenopausal Japanese women: the Miyagi Cohort Study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32159070" id="rid101" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          102 : Eating Pattern Response to a Low-Fat Diet Intervention and Cardiovascular Outcomes in Normotensive Women: The Women's Health Initiative.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9099655" id="rid102" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          103 : A clinical trial of the effects of dietary patterns on blood pressure. DASH Collaborative Research Group.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29800122" id="rid103" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          104 : Association of Low-Fat Dietary Pattern With Breast Cancer Overall Survival: A Secondary Analysis of the Women's Health Initiative Randomized Clinical Trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32031879" id="rid104" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          105 : Dietary Modification and Breast Cancer Mortality: Long-Term Follow-Up of the Women's Health Initiative Randomized Trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16467232" id="rid105" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          106 : Low-fat dietary pattern and risk of invasive breast cancer: the Women's Health Initiative Randomized Controlled Dietary Modification Trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26365989" id="rid106" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          107 : Mediterranean Diet and Invasive Breast Cancer Risk Among Women at High Cardiovascular Risk in the PREDIMED Trial: A Randomized Clinical Trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29378048" id="rid107" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          108 : Associations between Diet Quality Scores and Risk of Postmenopausal Estrogen Receptor-Negative Breast Cancer: A Systematic Review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28260236" id="rid108" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          109 : Mediterranean diet adherence and risk of postmenopausal breast cancer: results of a cohort study and meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16424129" id="rid109" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          110 : Diet quality is associated with the risk of estrogen receptor-negative breast cancer in postmenopausal women.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25833979" id="rid110" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          111 : Dietary patterns and breast cancer risk: a study in 2 cohorts.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23349252" id="rid111" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          112 : Fruit and vegetable intake and risk of breast cancer by hormone receptor status.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27170029" id="rid112" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          113 : Fruit and vegetable consumption in adolescence and early adulthood and risk of breast cancer: population based cohort study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20219961" id="rid113" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          114 : Dietary patterns and breast cancer risk: a systematic review and meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23221879" id="rid114" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          115 : Circulating carotenoids and risk of breast cancer: pooled analysis of eight prospective studies.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20181297" id="rid115" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          116 : Summary and meta-analysis of prospective studies of animal fat intake and breast cancer.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17374835" id="rid116" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          117 : Dietary fat and postmenopausal invasive breast cancer in the National Institutes of Health-AARP Diet and Health Study cohort.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25692500" id="rid117" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          118 : Dietary fat and breast cancer mortality: A systematic review and meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11369735" id="rid118" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          119 : Epidemiological assessment of diet: a comparison of a 7-day diary with a food frequency questionnaire using urinary markers of nitrogen, potassium and sodium.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12885485" id="rid119" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          120 : Are imprecise methods obscuring a relation between fat and breast cancer?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24586662" id="rid120" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          121 : Association between soy isoflavone intake and breast cancer risk for pre- and post-menopausal women: a meta-analysis of epidemiological studies.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30183083" id="rid121" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          122 : Consumption of red and processed meat and breast cancer incidence: A systematic review and meta-analysis of prospective studies.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29274927" id="rid122" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          123 : Red and processed meat consumption and breast cancer: UK Biobank cohort study and meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/14583769" id="rid123" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          124 : Dietary fat and breast cancer risk revisited: a meta-analysis of the published literature.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17101944" id="rid124" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          125 : Red meat intake and risk of breast cancer among premenopausal women.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17406351" id="rid125" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          126 : Meat consumption and risk of breast cancer in the UK Women's Cohort Study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27829237" id="rid126" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          127 : Dietary fibre intake and risk of breast cancer: A systematic review and meta-analysis of epidemiological studies.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12927030" id="rid127" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          128 : Breast cancer in Marin County.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15955253" id="rid128" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          129 : Spatial analysis of lung, colorectal, and breast cancer on Cape Cod: an application of generalized additive models to case-control data.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9230778" id="rid129" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          130 : Breast cancer clusters in the northeast United States: a geographic analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7494228" id="rid130" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          131 : Geographic variation in mortality from breast cancer among white women in the United States.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7494228" id="rid131" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          132 : Geographic variation in mortality from breast cancer among white women in the United States.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2358494" id="rid132" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          133 : Radiation exposure to patients receiving routine scoliosis radiography measured at depth in an anthropomorphic phantom.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2769783" id="rid133" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          134 : Breast cancer in women with scoliosis exposed to multiple diagnostic x rays.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26756460" id="rid134" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          135 : Radiation-Induced Breast Cancer Incidence and Mortality From Digital Mammography Screening: A Modeling Study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16648044" id="rid135" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          136 : Screening mammography and risk of breast cancer in BRCA1 and BRCA2 mutation carriers: a case-control study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22956590" id="rid136" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          137 : Exposure to diagnostic radiation and risk of breast cancer among carriers of BRCA1/2 mutations: retrospective cohort study (GENE-RAD-RISK).
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16801631" id="rid137" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          138 : Effect of chest X-rays on the risk of breast cancer among BRCA1/2 mutation carriers in the international BRCA1/2 carrier cohort study: a report from the EMBRACE, GENEPSO, GEO-HEBON, and IBCCS Collaborators' Group.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23625163" id="rid138" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          139 : Plasma vitamin D levels, menopause, and risk of breast cancer: dose-response meta-analysis of prospective studies.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32405914" id="rid139" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          140 : The effect of vitamin D supplementation on the risk of breast cancer: a trial sequential meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19001601" id="rid140" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          141 : Calcium plus vitamin D supplementation and the risk of breast cancer.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24131320" id="rid141" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          142 : Calcium plus vitamin D supplementation and health outcomes five years after active intervention ended: the Women's Health Initiative.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24131320" id="rid142" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          143 : Calcium plus vitamin D supplementation and health outcomes five years after active intervention ended: the Women's Health Initiative.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31733345" id="rid143" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          144 : Principal results of the VITamin D and OmegA-3 TriaL (VITAL) and updated meta-analyses of relevant vitamin D trials.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25589172" id="rid144" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          145 : Effect of COX-2 inhibitors and other non-steroidal inflammatory drugs on breast cancer risk: a meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22927520" id="rid145" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          146 : Use of aspirin, other nonsteroidal anti-inflammatory drugs, and acetaminophen and postmenopausal breast cancer incidence.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15998890" id="rid146" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          147 : Low-dose aspirin in the primary prevention of cancer: the Women's Health Study: a randomized controlled trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20567009" id="rid147" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          148 : Oral bisphosphonate use and breast cancer incidence in postmenopausal women.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20567021" id="rid148" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          149 : Use of bisphosphonates and risk of postmenopausal breast cancer.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22021667" id="rid149" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          150 : Bisphosphonate use after estrogen receptor-positive breast cancer and risk of contralateral breast cancer.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20160722" id="rid150" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          151 : Bisphosphonates for osteoporosis treatment are associated with reduced breast cancer risk.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28708471" id="rid151" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          152 : Use of Bisphosphonates and Risk of Breast Cancer in a French Cohort of Postmenopausal Women.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11049818" id="rid152" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          153 : Levels of seven urinary phthalate metabolites in a human reference population.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15121520" id="rid153" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          154 : Medications as a source of human exposure to phthalates.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24534276" id="rid154" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          155 : Urinary bisphenol A, phthalates, and couple fecundity: the Longitudinal Investigation of Fertility and the Environment (LIFE) Study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30629220" id="rid155" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          156 : Urinary Phthalate Biomarker Concentrations and Postmenopausal Breast Cancer Risk.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30995175" id="rid156" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          157 : Phthalate Exposure and Breast Cancer Incidence: A Danish Nationwide Cohort Study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8557223" id="rid157" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          158 : Risk of breast cancer in a cohort of infertile women.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2403111" id="rid158" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          159 : Infertility and breast cancer: a population-based case-control study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9620047" id="rid159" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          160 : Cancer incidence in a cohort of infertile women.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9620047" id="rid160" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          161 : Cancer incidence in a cohort of infertile women.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21852111" id="rid161" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          162 : Case-control study of shift-work and breast cancer risk in Danish nurses: impact of shift systems.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27758828" id="rid162" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          163 : Night Shift Work and Breast Cancer Incidence: Three Prospective Studies and Meta-analysis of Published Studies.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23975662" id="rid163" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          164 : A meta-analysis on dose-response relationship between night shift work and the risk of breast cancer.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16030307" id="rid164" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          165 : Urinary melatonin levels and breast cancer risk.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18544743" id="rid165" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          166 : Urinary 6-sulfatoxymelatonin levels and risk of breast cancer in postmenopausal women.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15051280" id="rid166" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          167 : Breast cancer and abortion: collaborative reanalysis of data from 53 epidemiological studies, including 83?000 women with breast cancer from 16 countries.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8988884" id="rid167" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          168 : Induced abortion and the risk of breast cancer.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16646050" id="rid168" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          169 : Breast cancer risk in relation to abortion: Results from the EPIC study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12800205" id="rid169" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          170 : Induced and spontaneous abortion and breast cancer risk: results from the E3N cohort study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17452545" id="rid170" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          171 : Induced and spontaneous abortion and incidence of breast cancer among young women: a prospective cohort study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12494478" id="rid171" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          172 : Abortions and breast cancer: record-based case-control study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12363327" id="rid172" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          173 : Organochlorines and breast cancer risk.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12363327" id="rid173" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          174 : Organochlorines and breast cancer risk.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19116389" id="rid174" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          175 : Vitamins C and E and beta carotene supplementation and cancer risk: a randomized controlled trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19565333" id="rid175" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          176 : Dietary beta-carotene, vitamin C and E intake and breast cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC).
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23416445" id="rid176" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          177 : Tubal sterilization and breast cancer incidence: results from the cancer prevention study II nutrition cohort and meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22020403" id="rid177" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          178 : Coffee intake and breast cancer risk in the NIH-AARP diet and health study cohort.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26291054" id="rid178" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          179 : Coffee, tea, caffeine intake, and the risk of cancer in the PLCO cohort.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19003966" id="rid179" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          180 : Cancer among Scandinavian women with cosmetic breast implants: a pooled long-term follow-up study.
         </p>
        </a>
       </div>
      </div>
     </div>
    </div>
   </section>
  </section>
  <!-- End Main Menu Area -->
  <!-- Start Search Popup Area -->
  <!-- End Footer Area -->
  <!-- Back to top -->
  <a class="scrolltop" href="#top">
   <i class="icofont-hand-drawn-up">
   </i>
  </a>
  <!-- End Back to top -->
  <!-- jQuery Min JS -->
  <!-- Prpper JS -->
  <!-- Bootstrap Min JS -->
  <!-- Classy Nav Min Js -->
  <!-- Owl Carousel Min Js -->
  <!-- Magnific Popup JS -->
  <!-- CounterUp JS -->
  <!-- Waypoints JS -->
  <!-- Form Validator Min JS -->
  <!-- Contact Form Min JS -->
  <!-- Main JS -->
  <!-- Global site tag (gtag.js) - Google Analytics -->
 </body>
</html>
